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ABSTRACT
Carbon nanotubes with their unique pseudo-one-dimensional nanostructures and
related electronic, optical, and mechanical properties have been attracting much attention
for potential biological applications, such as biosensors, bio-delivery, bioimaging and so
on. In this dissertation, recent studies and advances toward bioapplications of carbon
nanotubes are critically reviewed, followed by detailed reports on my research projects
concerning the use of carbon nanotubes as unique scaffolds for multivalent display of
sugars and the relevant results from bio-evaluation of these novel nanomaterials.
Single-walled (SWNTs) and multiple-walled carbon nanotubes (MWNTs) were
functionalized with amine-derivatived monosaccharides (galactoses and mannoses) and
their dendritic constructs. These sugar-functionalized carbon nanotubes were readily
water-soluble and biocompatible, and the intrinsic properties of the nanotubes were
largely preserved post-functionalization. The bio-evaluation of the functionalized carbon
nanotubes included experiments with pathogenic Escherichia coli O157:H7, in which
specific interactions of the galactose (or its dendritic construct)-functionalized SWNTs
with the E. coli cells to result in significant cell agglutination were observed. Similarly,
the mannose-functionalized SWNTs were found to bind effectively to Bacillus subtilis
(commonly used simulant for Bacillus anthracies or anthrax) spores for the formation of
large aggregates. Also interesting was the finding that there were unique carbohydratecarbohydrate interactions between SWNT-bound monosaccharides. All of the results
suggest that carbon nanotubes are indeed unique scaffolds for displaying multiple copies
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of sugars either individually or in pairs or quartets and that these unique nanomaterials
offer valuable biologically significant functions.
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CHAPTER I
INTRODUCTION-ADVANCES IN BIOAPPLICATIONS
OF CARBON NANOTUBES

Carbon nanotubes are pseudo-one-dimensional carbon allotropes of high aspect
ratio, high surface area, and excellent materials properties such as ultimate electrical and
thermal conductivities and mechanical strength.1-3 While these all-carbon hollow
graphitic nanomaterials may conceptually be viewed as “rolled-up” structures of one or
more layers of graphene sheets for single-walled (SWNT) or multiple-walled (MWNT)
carbon nanotubes, respectively, their formation is generally spontaneous in various
production methods. There have been major advances in the availability of carbon
nanotubes, both in quality and quantity, which has in turn stimulated the worldwide
pursuit of carbon nanotubes for technological applications.3,4 Nevertheless, carbon
nanotubes (especially SWNTs) are still relatively expensive, so that their uses in highervalue but lower-quantity technologies are probably better justified in the near term. As
one of such technological areas of enormous potentials, bioapplications of carbon
nanotubes have attracted much attention, with significant recent progress generating
much excitement in the research community.
The unique properties of carbon nanotubes offer a wide range of opportunities and
application potentials in biology and medicine. For example, the rich electronic
properties of carbon nanotubes have been explored for the development of highly
sensitive and specific nanoscale biosensors.5,6 Promising results have been produced on
the use of carbon nanotubes in various electroanalytical nanotube devices,7 and as

electromechanical actuators for artificial muscles.8 The optical absorption of carbon
nanotubes in the near-infrared has been used for the laser heating cancer therapy.9 In
recent years, the rapid development toward maturation of methodologies for the chemical
modification and functionalization of carbon nanotubes has helped to address many
biocompatibility-related issues, opening up an even wider range of bioapplication
opportunities in areas such as drug delivery,10 bioconjugation and specific recognition,
including interestingly the use of sugar-functionalized carbon nanotubes to bind and
aggregate anthrax spores.11 The biological fate and consequences of carbon nanotubes in
vitro and in vivo have also been investigated for an understanding of the important issues
on environmental impact and toxicity.12
Here we report the recent advances in the chemical modification of carbon
nanotubes targeting specifically their bioapplications, review various approaches and
developments toward the use of carbon nanotubes in biology and medicine, and provide
some perspectives on further investigations and emerging opportunities.

1.1 Functionalization of Carbon Nanotubes

There has been significant recent progress in the development and implementation
of various covalent and non-covalent functionalization methods for chemical
modification and solubilization of carbon nanotubes.13-15 The maturation that has been
achieved in the functionalization and especially the aqueous solubilization of carbon
nanotubes is particularly beneficial to the biocompatibilization of the nanotubes toward
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bioapplications. Among now widely used covalent functionalization approaches are
addition reactions (Scheme 1.1) derived from those traditionally for graphite surfaces or
established for fullerenes, and coupling reactions targeting oxidized defect sites on the
carbon nanotube surface, commonly the surface defect-derived carboxylic acid moieties
to react with amines and alcohols for amide and ester linkages, respectively (Scheme 1.2).
For some functional groups such as amines, the covalent amidation functionalization is
likely accompanied by significant non-covalent interactions or the adsorption of the
functional groups on the nanotube surface, thus substantially improving some properties
of the functionalized nanotube samples (such as excellent aqueous solubility for a
hydrophilic functionalization agent16).
Non-covalent approaches can usually preserve the structures and properties of
carbon nanotubes after functionalization,17 thus are equally important to the biocompatibilization and bio-applications of the nanotubes.15 Among commonly used
schemes are surfactant dispersion,18 π-π stacking with aromatic compounds,19 and
polymer wrapping.20
Besides synthetic polymers and small molecules, biological or bioactive species
are used in the functionalization of carbon nanotubes for not only aqueous solubility but
also enhanced bio-compatibilities and bio-recognition capabilities. Various proteins,
DNAs, and carbohydrates have been covalently or noncovalently functionalized with
carbon nanotubes, producing highly aqueous stable and biocompatible bio-carbon
nanotube systems (Scheme 1.3). Some of the recent advances in this area are highlighted
below.

3

Scheme 1.1 Covalent addition reactions on the sidewall of carbon nanotubes.

4

Scheme 1.2 Covalent reactions targeting carboxylic acids (derived from nanotube
surface defects)

5

Polysaccharides wrapping[41]

Protein adsorption[21]

DNA wrapping[53]

Scheme 1.3 Noncovalent biofunctionalized carbon nanotubes.
(From Ref. [21], [41], [53])
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1.1.1 Proteins and Peptides
Non-specific adsorption is a commonly used method for preparing protein (and/or
peptide)-carbon nanotube conjugates. For example, Nepal and Geckeler reported the
dispersion and debundling of SWNTs with different proteins such as lysozyme, histone,
hemoglobin, myoglobin, ovalbumin, bovine serum albumin, trypsin, and glucose
oxidase.21 The dispersion ability of the proteins depends on various factors including
their primary structure and pH. Proteins (histone and lysozyme) with higher basic
residues contents were found to disperse carbon nanotubes better. The higher cationic (or
anionic) charge density at a pH below (or above) isoelectric point may contribute to the
repulsion of protein-stabilized SWNTs, thus less aggregation and better dispersion.21
Hydrophobin (HFBI) is an amphiphilic protein and can self-assemble into
monomolecular film at the air-water interface. With the aid of sonication, Kurppa et al.
solubilized as-produced SWNTs with HFBI.22 The nanotubes were found to be embedded
in the HFBI film. By engineering HFBI protein with gold nanoparticle, these same
authors also prepared an interesting hybrid 1-D nanostructure of gold nanoparticles
attached onto nanotube sidewalls in 2.6 nm spacing.22
Mechanistically, electrostatic interactions as well as hydrophobic interactions
(especially π-stacking) are recognized to play critical roles in protein-carbon nanotube
interactions.23-26 For example, it has been suggested that the electron density of the
aromatic residue on the hydrophobic face of the amphiphilic helical peptides can affect
their efficiency in nanotube dispersion.23 Yan and coworkers studied interactions between
functionalized MWNTs (in different diameters and surface functionalities) and various
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proteins.24 Their results showed that the larger-diameter MWNTs were favored in the
binding with proteins, and the binding was enhanced by the negative charges associated
with nanotube functionalities and also affected by the surface electrostatic and
stereochemical properties of the proteins.24
Honek’s group recently identified a SWNT-binding motif (the tryptophan residue
in a peptide called UW-1) through phage-displayed peptide library screening. Their study
suggested that hydrophobic as well as π-stacking interactions between the tryptophan
residue in UW-1 and the SWNT sidewall may dictate the high binding affinity of UW-1
to SWNTs.25 In a follow-up study, the tryptophan residue was altered and the effect of
the alteration to the binding to SWNTs was evaluated. The experimental results
combining with computational modeling indicated that the highest occupied molecular
orbital of tryptophan residue interacts with the lowest unoccupied molecular orbital of
SWNT.26
Although the non-covalent binding is a versatile way to functionalize carbon
nanotubes with proteins, the interaction is rather weak in comparison to covalent binding.
For example, it has been reported that the nanotube-adsorbed proteins were largely
removed via dialysis against water at room temperature, while covalently attached ones
were stable under the same treatment.27
As a classic example in covalent functionalization of carbon nanotubes with
proteins, Sun and coworkers reported that carbon nanotubes could be functionalized with
bovine serum albumin (BSA) or horse spleen ferritin via carbodiimide-activated
amidation reaction.28,29 The BSA-functionalized SWNTs (BSA-SWNT) were then
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conjugated with goat anti-Escherichia coli O157 (Ab1) to form immuno-SWNT under
physiologically compatible conditions. Compared to BSA-SWNT, the immuno-SWNT
were capable of recognizing pathogenic E. coli O157:H7 cells through specific antibodyantigen interactions, as confirmed by SEM imaging results.30 The bacterial recovery
determined by colony enumeration was as high as 80-90% when a larger amount of
immno-SWNT and/or a high initial bacterial count were used.31
The same platform was used to prepare BSA-functionalized MWNTs.32 After
magnetic separation, those nanotubes with iron or iron oxide encapsulation were isolated
and coated with anti-E. coli O157. The resulting “immunomagnetic MWNTs” were
evaluated in immnomagnetic separation of E. coli O157:H7 cells in pure and mixed (with
Salmonella typhimurium) cultures. The immunomagnetic MWNTs were able to
efficiently capture and precipitate E. coli in aqueous media in a commercial magnetic
separator within 5 min (Figure 1.1).32 Such capture was sensitive to approximately 40
bacterial counts per 100 µL aqueous buffer, and highly selective with no bound
background bacteria even at a relatively high interfering concentration (e.g. selective
toward E. coli O157:H7 at 800 CFU/100 µL with background flora of S. typhimurium
DT104 cells at ~3,000 CFU/100 µL).32
The same amidation reaction was employed by Kane and coworkers to covalently
functionalize MWNTs with a specific peptide sequence, which specifically binds to the
heptameric receptor-binding subunit of anthrax toxin.33 These nanotube-peptide
conjugates were found to selectively destroy anthrax toxin with the reactive oxygen
species generated by the nanotubes in near-IR radiation.33
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In addition to the direct amidation, proteins were also covalently attached to
carbon nanotubes through a secondary bond which is usually cleavable under controlled
condition. You et al. recently reported a BSA-conjugated MWNTs via disulfide linkage
which can be cleaved at a glutathione concentration of 20 mM thus to release BSA. In
their procedure, acid-treated MWNTs were first covalently bound with pyridyldithio
groups through traditional defect site amidation reaction, and the pyridyldithio-MWNT
complex was then conjugated with BSA in disulfide-exchange reaction.34

1.1.2 Carbohydrates
Carbohydrates are highly hydrophilic biomolecules and extensively used in the
functionalization of carbon nanotubes through either defect site covalent bonding or noncovalent wrapping. In addition to their high aqueous solubility and biocompatibility,
carbohydrates-functionalized carbon nanotubes represent a unique class of pseudo onedimensional sugar arrays of unusual properties.11,35 Many of these properties are not
available to multivalent sugar ligands displayed on traditional scaffolds such as polymers,
dendrimers, and proteins. For example, Sun and coworkers demonstrated that the
monosaccharide (galactose or mannose)-functionalized SWNTs could effectively bind
and aggregate anthrax (Bacillus anthracis) spores in the presence of a divalent cation like
Ca2+ (Figure 1.2).11 The overall effectiveness in the aggregation of B. anthracis spores
was assessed as up to 97.7% CFU reduction in laboratory setting. The binding was found
to be reversible by adding ethylene diamine tetraacetic acid (EDTA), which is a chelating
agent for Ca2+. The results suggested that the binding was likely due to Ca2+-mediated
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Figure 1.1 (a) A scheme on the formation of immunomagnetic-MWNT and their
interaction with E. coli cells; (b) a high magnification TEM image of the
magnetic-MWNT-BSA sample; (c) SEM images of the immunomagnetic
separation sample showing E. coli cells bound with immunomagneticMWNT species. (From Ref. [32])
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B. Anthracis Spores

Figure 1.2 (a) SEM (scale bar = 500 nm) and (b) optical microscopy (scale bar
= 20 µm) of the Ca2+-mediated aggregation of anthrax spores with
sugar functionalized SWNTs; (c) A schematic illustration of such
aggregation. (From Ref. [11])
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Figure 1.3 (top) The chemical structures of schizophyllan and curdlan. (a) TEM
image of as-grown-SWNT/s-SPG composite, and (b,c) its magnified
picture. (d) The original image of (c) was Fourier filtered to enhance
the contrast of the composite. (From Ref. [41])
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carbohydrate-carbohydrate interactions between the SWNT-displayed multivalent
monosaccharides and the spore surface sugars. Interestingly, the experiments with same
sugars-functionalized polymeric nanoparticles (~120 nm in diameter polystyrene beads)
did not show any spore aggregation under same experimental conditions, suggesting that
the observed binding and spore aggregation were unique to multivalent sugar ligands
displayed on SWNTs.11
According to an earlier report from the same research group, the galactosefunctionalized SWNTs (Gal-SWNT) were used to bind and agglutinate pathogenic E. coli
O157:H7 cells.35 The binding required no divalent cations and was specific to β-Dgalactose- but not α-D-mannose- or BSA-functionalized nanotubes, indicating that the
multivalent interactions between the nanotube-bound galactoses and the E. coli cell
surface galactose-binding proteins probably dictate the Gal-SWNT mediated aggregation
of E. coli cells.
The multivalency of carbohydrate ligands should in principle affect significantly
the overall affinity of multivalent ligand-receptor interactions.36 Thus, a series of
dendritic galactopyranosides and mannopyranosides were synthesized for their
functionalization of SWNTs to increase the valency of the sugar ligands displayed on
each nanotube as well as to improve the aqueous solubility of the functionalized
nanotubes.37,38 According to the bio-evaluation of those sugar dendron-functionalized
carbon nanotubes by using established binding assays with E. coli cells, the β-D-galactose
dendron-functionalized SWNTs (Gal2-SWNT), compared to simple β-D-galactosefunctionalized SWNTs (Gal-SWNT), had more effective CFU reduction in the agglutina-
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tion of E. coli cells.38
The non-covalent wrapping with polysaccharides is another commonly used
approach in the carbohydrate functionalization and solubilization of carbon
nanotubes.39,40-42 For example, Liu et al. used alginic acid (AA), a natural polysaccharide
constituted with repeated β-D-mannuronic acid (M) and α-L-guluronic acid (G) segments,
to solubilize raw MWNTs by sonication.40 The TEM and NMR studies of MWNT-AA
complex showed that MWNT was partially wrapped by AA in possibly a way of M
segments lying on the nanotube sidewall while part of G segments standing up on it. The
addition of divalent or trivalent metal cations, such as Zn2+, Ni2+, Co2+, Pb2+, La3+ and
Eu3+, resulted in precipitation of the MWNT-AA complex. The precipitation could be redispersed in water by chelating the metal cations with EDTA.40
Schizophyllan (SPG) is a polysaccharide with natural triple helix (t-SPG)
structure which can be dissociated to single chain (s-SPG) in DMSO. The triple helix
structure (t-SPG) can be recovered in a simple exchange of DMSO with water. Similar to
that in cyclodextrin, the inside hollow of helical column in SPG is considered as
hydrophobic, thus could entrap SWNTs through hydrophobic interactions. Shinkai and
coworkers prepared SPG- and curdlan- (an analogue of SPG containing the main chain
but not the side chain) wrapped SWNTs through first mixing/sonicating in DMSO and
then exchanging with water.39,41,42 The microscopy characterization showed a unique
periodical stripe structure in SWNT/s-SPG complex with two s-SPG chains right-handed
helically wrapped on one nanotube. This was the first visual image that clearly
demonstrated a patterned structure of water-soluble polymer wrapped SWNTs (Figure
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1.3).41 The similar patterned structure was observed later in the case of Amylose-wrapped
SWNTs.43

1.1.3 DNAs/RNAs
DNA- and RNA-functionalized carbon nanotubes hold interesting prospects in
various fields including biosensors44 and gene delivery.45 Similar to proteins and
carbohydrates, DNA can be conjugated to carbon nanotubes through either non-covalent
adsorption46-48 or covalent functionalizations in terms of direct amidation49,50 or the use of
a bifunctional linker.51 For example, Hamers and coworkers used the bifunctional linker
approach to functionalize carbon nanotubes with single-strand DNAs (ssDNA).51 The
procedure included several steps, first the sidewall functionalization of SWNTs with 4nitrobenzenediazonium salt, then the electrochemical reduction of -NO2 to -NH2 for
reaction with a heterobifunctional cross-linker to introduce a maleimide group, followed
by coupling with 5’-thiol-modified ssDNA (Scheme 1.4).51 The nanotube-bound ssDNAs
were able to recognize their appropriate complementary sequence with a high degree of
selectivity.
The specific interaction between DNA sequences on the carbon nanotube surface
facilitates the assembly of nanotubes into architecture necessary for electrical circuits and
molecular sensing applications. The DNA-directed multicomponent self-assembly of
carbon nanotubes and gold nanoparticles has been demonstrated.47-49 For example, Mao
et al. grafted ssDNA onto nanotube surface via non-covalent wrapping.47 The ssDNASWNT complex then hybridized with complimentary DNA-coated gold nanoparticles
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(prepared through thiol-gold interaction). Interestingly, the DNA-directed assembly was
found to be a reversible process, the formation at low temperature and dissociation at
high temperature.47 Similarly, Deng and coworkers prepared a thiolated DNA strand
d(GT)29SH to wrap SWNT, which was later used as a rigid template for the assembly of
gold nanoparticles.48
The functionalization of carbon nanotubes with DNAs allows a precise control of
their interfacial properties. Dai and coworkers non-covalently adsorbed poly-T DNA onto
SWNT sidewalls, which were well dispersed and used for ultrathin atomic layer
deposition of HfO2 for high k dielectrics.44 With the ~3 nm HfO2 coating, high
performance SWNT field effect transistors (FETs) free of gate-leakage were obtained.
The same group also grafted short interfering RNA (siRNA) onto the SWNT surface.45 In
their strategy, SWNTs were first non-covalently coated with amine-terminated
phospholipid-polyehtyleneglycol (PL-PEG), and the amine attached to the nanotube was
then covalently coupled with thiol-modified siRNA. The resulting siRNA-SWNT
conjugates exhibited efficient silencing effects (50-60% knockdown) on both CD4
receptor and CXCR4 co-receptor (required for HIV entry into human T cells and
infection).45
The DNAs attached to carbon nanotubes were shown to mostly preserve their
biological activity.52 For example, luciferase DNAs containing T7 promoter sequence
required for in vitro transcription were adsorbed onto SWNT bucky papers. Compared to
free DNAs, ~36% of the nanotube-bound DNAs remained functional in terms of RNA
polymerase-catalyzed transcription/translation reaction.52 Strano et al. found that the
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double-stranded DNA non-covalently wrapping SWNTs preserved its property of the
conformation transition from right-handed B form to the left-handed Z form upon the
addition of divalent cations such as Hg2+, which causing a detectable red shift in bandgap emission of SWNTs. Thus, these DNA-wrapped nanotubes were used as a detecting
agent for the ion in whole blood and tissue and within living mammalian cells (Figure
1.4).53 However, in some cases, the bounded carbon nanotubes can interfere with the
normal DNA activities. For instance, a recent study by Qu and coworkers also found that
the attachment of SWNTs to human telomeric i-motif DNA dramatically changed its
kinetics of S1 cleavage by increasing the turnover number 22-fold over that of free DNA
alone.54
The interaction between DNA and carbon nanotubes is stable enough to allow for
separation of the dispersed nanotubes into well-defined sub-populations.46,55,57 Recently,
ssDNA-wrapped SWNTs were separated into multiple fractions with different length
distributions, and each fraction was examined for cellular toxicity to various cell lines.55
As demonstrated experimentally, while the longer SWNTs (>200 nm) were excluded by
cells, the shorter ones were found to internalize into the cytoplasm, causing significantly
decreased metabolic activity.55 Therefore, shorter SWNTs may be more toxic to cells
than longer ones.
The DNA-carbon nanotube interaction is a complicated and dynamic process.
Many studies on this subject have been pursued through a series of techniques including
molecular dynamic simulation, microscopy, circular dichroism (CD), and optical
spectroscopy.57-61 Although the detailed mechanism is not fully understood at present,
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Scheme 1.4 Schematic illustration of addressable biomolecular functionalization of
carbon nanotubes. (From Ref. [51])
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Figure 1.4 (A) Concentration-dependent fluorescence response of the DNAencapsulated (6, 5) nanotube to divalent chloride counterions. The inset
shows the (6, 5) fluorescence band at starting (blue) and final (pink)
concentrations of Hg2+. (B) Fluorescence energy of DNA-SWNTs inside a
dialysis membrane upon removal of Hg2+ during a period of 7 hours by
dialysis. (C) Circular dichroism spectra of unbound d(GT)15 DNA at various
concentrations of Hg2+. (D) DNA-SWNT emission energy plotted versus
Hg2+ concentration (red curve) and the ellipticity of the 285-nm peak
obtained via circular dichroism measurements upon addition of mercuric
chloride to the same oligonucleotide (black curve). Arrows point to the axis
used for the corresponding curve. (E) Illustration of DNA undergoing a
conformational transition from the B form (top) to the Z form (bottom) on a
carbon nanotube. (From Ref. [53])

20

several physical factors have been proposed to be driving DNA-carbon nanotube
interactions,46,59-61 such as entropy loss due to confinement of the DNA backbone, van
der Waals and hydrophobic (π-stacking) interactions, electronic interactions between
DNA and carbon nanotubes, and nanotube deformation. A recent UV optical
spectroscopy study of the ssDNA-SWNT system demonstrated experimentally that πstacking was a force behind the DNA-SWNT binding, and the bound nucleotides were
probably oriented along the nanotube’s long axis.60 This was later confirmed by
Golovchenko et al. in their study based on the time-dependent density functional theory
(TDDFT) and optical spectroscopy measurements of the DNA-SWNT complex.61 Their
results suggested that the DNA bases were orientated relative to the nanotube axis, and
the orientation mainly depended on the base identity instead of the diameter and chirality
of the nanotubes.61
Generally, DNA-nanotube conjugates are widely pursued for their interesting and
promising prospects in a number of areas, including especially nanoscale devices,
biosensors, electronic sequencing, and therapeutic delivery, taking advantage of the
unique pseudo-one-dimensional cylindrical structure of carbon nanotubes and the
sequence-specific pairing interaction and conformational flexibility of DNA.

1.2 Bioapplications of Carbon Nanotubes

As reviewed above, there has been significant progress in addressing some
fundamental and technical issues in the functionalization and solubilization of carbon
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nanotubes with various biomolecules and bioactive species. It has stimulated the
exploration of carbon nanotubes for applications in a variety of biological and biomedical
systems and devices. Here some interesting recent studies and achievements for the use
of carbon nanotubes in biosensors, bio-delivery, bioimaging, tissue engineering, and
related results on toxicity and bio-distribution are highlighted and discussed.

1.2.1 Biosensors
Carbon nanotubes, especially SWNTs, with their fascinating electrical properties,
dimensional proximity to biomacromolecules (e.g. DNA of 1 nm in size), and high
sensitivity to surrounding environments, are ideal components in biosensors not only as
electrodes for signal transmission but also detectors for sensing biomolecules and biospecies. In terms of configuration and detection mechanism, biosensors based on carbon
nanotubes may be divided into two categories: electrochemical sensors and field effect
transistor (FET) sensors. Since a number of recent reviews on the former have been
published,6,62,63 our focus here is mostly on FET sensors.
Generally, a carbon nanotube FET device is constructed by a substrate (gate), two
micro-electrodes (source and drain), and bridging material between the electrodes, which
is typically an individual SWNT or a SWNT network. A SWNT FET is usually
fabricated by casting a dispersion of bulk SWNTs or directly growing nanotubes on the
substrate by CVD either before or after the electrodes are patterned.64 Due to the
diffusive electron transport properties of semiconducting SWNTs, the current flow in
SWNT FET is extremely sensitive to the substance adsorption or other related events on
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which the sensing is based.
A wide variety of applications for SWNT FET have been explored, especially for
the detection of proteins, antibody-antigen interactions, carbohydrates, DNAs and their
hybridization, and single nucleotide polymorphism.6 The detection limit for the sensing
of proteins or protein-protein interactions has generally been in the range of 100 pM to
100 nM.65 In a recent study, however, Byon and Choi improved the sensitivity to 1 pM
for both nonspecific and specific protein bindings by modifying the geometry of the
SWNT FET device.66 The substantially higher sensitivity (a factor of 10,000) was
accredited mainly to the larger Schottky contact area on electrodes, which was achieved
by angled deposition of electrode metals. This work might contribute to an acceleration in
the progress toward the realization of nanoscale and label-free electronic biosensor
systems.
Although antibodies are often used as specific targeting agents in FET devices for
highly selective biosensing,65-67 they are typically not very stable and their large sizes
(10-15 nm) may sacrifice the detect sensitivity in some cases. Alternatively, synthetic
oligonuleotides (i.e. aptamers) have been demonstrated for their advantages (stability,
small size, etc.) in the specific detection of amino acids, drugs, and proteins. For example,
Maehashi et al. immobilized 5’-amino-modified aptamer onto the nanotube surface with
the aid of a linker molecule, 1-pyrenebutanoic acid succinimidyl ester. The corresponding
FET device exhibited a sharp decrease in the source-drain current in the presence of
immunoglobulin E (IgE) target, with the detection limit down to 250 pM.68 Compared to
the IgE-mAb (monoclonal antibody against IgE)-modified carbon nanotube FET devices,
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the aptamer-modified ones were better performing in the detection of IgE under similar
experimental conditions.68
Star et al. recently reported the synthetic oligonucleotide-immobilized carbon
nanotube FETs as selective detectors for DNA immobilization and hybridization.69 Their
device could specifically recognize target DNA sequences, including H63D singlenucleotide polymorphism discrimination in HFE gene (responsible for hereditary
hemochromatosis).69 The addition of divalent cation Mg2+ dramatically increased
sensitivity by three orders of magnitude to reach the detection limit of 1 pM.69 As
reported by Li and coworkers, synthetic oligonucleotide-immobilized SWNT networks
could also be fabricated with two different metal contacts (Au and Cr) for electrical
detection of DNA hybridization.70 Upon DNA hybridization, the drain current (Id)
increased in Cr-contacted FET device while decreased in Au-contacted one, indicating
that the electrode-SWNT interface played an important role in the electrical signal
transmission.70
While it is generally acknowledged that SWNT devices are operated in terms of
the Schottky barrier modulation effect,65,71 as well as the chemical gating effect,72,73 the
sensing mechanism for nanotube-based FETs still remains a subject of debate. According
to a recent report, experimentally the effect of protein adsorption on the relationship (I-V
curve) between source-drain current and the liquid gate potential could be used as a tool
to identify the sensing mechanism in the SWNT transistor (Figure 1.5).74 It was found
that the sensing was indeed due to a combination of Schottky barrier and electrostatic
gating effects. The finding was consistent with another recent study of DNA immobiliza-
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Figure 1.5 Experimental layout and results of a typical biosensing experiment. (a)
Atomic force microscopy topology image of a SWNT between Cr/Au
contacts on an insulating SiO2 substrate. (b) Measurement setup, where a
source-drain bias potential is applied and the device is gated through an
Ag/AgCl reference electrode inserted in the electrolyte. The electrolyte is
contained in a home-built flow cell (not depicted). (c) Band diagram for a
holedoped SWNT showing electron conduction through thermally
activated carriers into conductance band and hole conduction through
tunneling through the Schottky barrier. EF is the Fermienergy. EC and EV
are the energies of SWNT conductance and valence band edges
respectively. The liquid gate potential changes the doping level in the bulk
of the SWNT as indicated by the red arrows. (d) Results of a typical
biosensing experiment. Current versus liquid gate potential curves acquired
before (black line) and after (red line) adsorption of 1 µM HHCC in PB
buffer (Vsd = 10 mV). The inset shows the real-time drop in conductance
when HHCC is flushed over the device, while the gate potential is held
constant at -50 mV vs Ag/AgCl, (as indicated by the blue dashed line).
(From Ref. [74])
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-tion on back-gated SWNT network.72 While earlier reports suggested that the sensitive
region was limited to the nanoscale contacts,65,66 these new results indicated that it could
also extend to the bulk channel section of the SWNT.
As discussed earlier, semiconducting SWNTs are the ones useful in nanotubebased FET devices.63,75 With rare exceptions,76 however, as-produced SWNTs are
mixtures of semiconducting and metallic nanotubes (in a ratio close to the statistical limit
of 2-to-1).77 Therefore, the selective removal of metallic SWNTs for purer
semiconducting ones, such as by improving the post-fabrication electrical breaking down
technique78 or taking advantage of the recent advances in post-production separation of
semiconducting SWNTs from the as-produced mixtures,77,79,80 may prove highly
beneficial.

1.2.2 Bio-Delivery
The current cancer and gene therapy requires the internalization of desired drugs
and genes into the target cells. However, most anticancer drugs and genes suffer from
low cellular uptake. Many delivery systems, such as liposomes, polymers, dendrimers,
and a variety of nanomaterials, are developed for the need. Carbon nanotubes for their
unique ability of penetrating cell membranes without the need for any external transporter
system are particularly interesting as potential delivery vehicles. In the literature,
nanotubes have been demonstrated as effective carriers for shuttling and delivering
various peptides, proteins, nucleic acids, and small-molecule drugs into living cells.10
Methotrexate (MTX) is a widely used anticancer drug, though it has a very low
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cellular uptake. Prato, Bianco and coworkers employed a “double functionalization”
strategy to attach both fluorescein isothiocyanate (FITC, a fluorescent probe) and MTX
onto the sidewall of MWNTs (1,3-cycloaddition of azomethine ylides).81 In their
procedure, carbon nanotubes were first co-functionalized with two orthogonally protected
amino groups that were selectively de-protected and subsequently derivatized with FITC
and MTX. As demonstrated in the in vitro study with Jurkat cells, the nanotube-bound
MTXs were rapidly internalized into cells and accumulated in the cell cytoplasm.81 The
same group of researchers prepared MWNT-doxorubicin (DOX, a popular anticancer
drug) supramolecular complex through presumably the π-stacking interactions between
the nanotube sidewall (MWNTs suspended by pluronic copolymer) and the DOX
aromatic hydroxyl-anthraquinonic rings.82 The fluorescence intensity of the MWNTbound DOX was suppressed due to the nanotube quenching effect. The toxicological
assay with MCF-7 human breast cancer cells suggested a significant enhancement in
cytotoxicity of the MWNT-DOX complex as compared to the free DOX and
DOX/pluronic mixture. Since pluronic copolymer-dispersed MWNTs did not exhibit any
toxicity, the enhanced cytotoxicity of the MWNT-DOX complex was attributed to an
effective delivery of DOX into MCF-7 cells via MWNTs.82
Dai and coworkers have been extremely active in studies of using carbon
nanotube as delivery vehicles.9,45,83-84 According to their recent report83 on the cellular
delivery of a large amount of DOX via SWNTs, two aqueous soluble SWNT samples
were prepared, with one (PL-SWNT) from the non-covalent suspension with
phospholipid-polyehtyleneglycol (PL–PEG, ~120 PEG units) and the other (PEG-SWNT)
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from covalent functionalization with PEG (220 units). These samples were used for the
non-covalent attachment of DOX through π-stacking. The binding of DOX to and their
dissociation from SWNT were found to be dependent on pH and the nanotube diameter,
generally lower pH and smaller diameter in favor of DOX dissociation from the
nanotube.83 The in vitro toxicity study with U87 cancer cell showed significant cell death
and cell apoptosis induced by the DOX-attached SWNTs (PL-SWNT-DOX), while PLSWNT (no DOX loading) exhibited no toxic effect on cells. The IC50 (half-maximum
inhibitory concentration) value for PL-SWNT-DOX was estimated to be ~8 µM, higher
than that of the free DOX (~2 µM). For specifically targeting U87 cancer cells, a cyclic
arginine-glycine-aspartic acid peptide (RGD, targeting integrin αvβ3 receptors upregulated in many solid tumors) was conjugated to the terminal amine groups in PLSWNT. The bio evaluation on the effectiveness of RGD-conjugated PL-SWNT-DOX
showed a lower IC50 value of ~3 µM for RGD-positive U87 cancer cells, but no
improvement for MCF-7 cells (short of corresponding receptors, negative control). The
enhanced toxicity of RGD-conjugated PL-SWNT-DOX was attributed to the targeted
intracellular delivery of DOX (Figure 1.6).83
Similarly, Dai, Lippard, and coworkers covalently tethered PL-PEG (45 PEG
units) with a platinum (IV) predrug complex to be used for the dispersion of SWNTs
through hydrophobic interactions.84 The resulting platinum (IV) complex-SWNT
conjugates [SWNT-Pt(IV)] showed dramatic enhancement of cytotoxicity to Ntera-2
cancer cells, while the free platinum (IV) complex was nearly non-toxic. The cellular
platinum concentration of SWNT-Pt(IV) was six times of that of the free platinum (IV)
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Figure 1.6 RGD peptide selectively enhances doxorubicin delivery by SWNTs and
toxicity to integrin αvβ3-positive cells. (a) Schematic structure of PLSWNT-RGD-DOX, i.e., SWNT functionalized with RGD at the termini of
PEG and loaded with doxorubicin on the sidewall by π-stacking. (b)
Confocal fluorescence images of integrin αvβ3-U87MG cells (top) and
negative MCF-7 cells (bottom) treated with either PL-SWNT-DOX (right)
or PL-SWNT-RGD-DOX (left). The concentration of DOX was 2 µM in
all experiments. The U87MG cells incubated with PL-SWNT-RGD-DOX
showed stronger DOX fluorescence in the cells than in the other three
cases. (c,d) Concentration dependent survival curves of U87MG cells (c)
and MCF-7 cells (d) treated by various samples, as indicated. The viable
cell percentage was measured by the MTS assay. PL-SWNT-DOX had a
lower toxic effect than free DOX on both types of cells, while PL-SWNTRGD-DOX exhibited increased toxicity to U87MG cells but not to MCF-7
cells. (From Ref. [83])
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Figure 1.7 Selective targeting and killing of cancer cells. (a) Chemical structure of PLPEG-FA and PL-PEG-FITC, for solubilizing individual SWNTs. (b)
(Upper) Schematic of selective internalization of PL-PEG-FA-SWNTs into
folateoverexpressing (FR+) cells via receptor binding and then NIR 808-nm
laser radiation. (Lower) Image showing death of FR+ cells with rounded
cell morphology after the process in Upper (808-nm laser radiation at 1.4
W/cm2 for 2 min). (Inset) Higher magnification image shows details of the
killed cells. (c) (Upper) Schematic of no internalization of PL-PEG-FASWNTs into normal cells without available FRs. (Lower) Image showing
normal cells with no internalized SWNTs are unharmed by the same laser
radiation condition as in b. (Inset) Higher magnification image shows a live
normal cell in stretched shape. (d) Confocal image of FR+ cells after
incubation in a solution of SWNTs with two cargoes (PL-PEG-FA and PLPEG-FITC). (e) The same as d for normal cells without abundant FRs on
cell surfaces. (Magnifications: ×20.) (From Ref. [9])
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complex alone, suggesting the effective delivery of platinum (IV) via SWNTs.84
Beyond small-molecule drugs, other bioactive species such as nucleic acids were
also successfully delivered into the cell by using carbon nanotubes.45,85 Zhang et al.
functionalized SWNTs with –CONH-(CH2)6-NH3+Cl- to mediate the conjugation of
siRNA with specifically targeted murine telomerase reverse transcriptase (mTERT)
expression to form the mTERT siRNA:SWNT+ complex.85 These specifically
biofunctionalized SWNTs successfully entered tumor cell lines, silencing the expression
of the targeted gene, inhibiting cell proliferation and promoting cell senescence in vitro,
as well as suppressing tumor in vivo.85 Similarly, siRNA was grafted onto carbon
nanotubes for delivery into human T cells and primary cells, which exhibited superior
silencing effects over conventional liposome-based non-viral agents.45
As mentioned earlier, the exceptional cell membrane-penetrating ability combined
with the near-infrared (NIR) absorption characteristics of carbon nanotubes make them
suitable materials in hyperthermia cancer therapy.9 Kam et al. conjugated Cy3-labeled
single-stranded DNA with SWNTs (DNA-SWNT), which were internalized into HeLa
cells and cumulated in the cytoplasm region. It was found that the DNA was dissociated
from SWNTs and entered into the cell nucleus upon six 10-second on-and-off pulses of
1.4 W/cm2 laser radiation at 808 nm, and the continued exposure under the same
radiation for 2 min induced cell death. This was most likely due to the extensive local
heating generated by the NIR absorption of SWNTs inside the cells.9 To selectively target
and kill cancer cells, the folic acid (FA)-terminated phospholipid-polyehtyleneglycol
(PL-PEG)-functionalized SWNTs (PL-PEG-FA-SWNTs) were synthesized and incubated
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with folate-overexpressing (FR+, receptors for FA ligands) HeLa cells and also normal
cells before laser radiation. Extensive death in the FR+ cells was observed, while the
normal cells maintained normal proliferations (negative control, Figure 1.7).9 The direct
injection of SWNTs into tumor cells to induce cell death by NIR radiation represent an
attractive alternative to endocytosis for applications in cancer therapeutics.9
For eventual in vivo applications of the widely pursued carbon nanotube delivery
systems, a critical challenge is to be able to keep the nanotubes in the bloodstream long
enough for their intended functions.86 In a recent study by Yang et al., the oligomeric
poly(ethylene glycol) functionalization (PEGylation) of SWNTs was found to be
remarkably effective in achieving prolonged blood circulatinon (half-time on the order of
20 hours for the PEGylated nanotubes).87 Experimentally, skeleton 13C-enriched SWNTs
were functionalized with the oligomeric PEGs by targeting the nanotube surface defects
in well-established reactions. The plasma pharmacokinetic study was performed by
injecting male KM mice intravenously with a solution of the PEGylated SWNTs, and by
quantifying the nanotube concentrations in the blood post-exposure at different time
intervals in terms of the

13

C isotopic abundance determination (isotope ratio mass

spectrometry). At one day post-exposure, for example, about 30% injected dose (%ID)
remained in blood circulation,87 compared to only 0.2%ID for pristine SWNTs at the
same time post-exposure.88 In a similar study by Dai and coworkers, a comparable blood
circulation time was obtained for SWNTs non-covalently functionalized with branched
PEGs.89 There were also preliminary results87 suggesting that the tumor uptake of the
PEGylated SWNTs benefited from their prolonged blood circulation. For the EMF6
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model (breast cancer in BABL/c mice) and the Lewis model (lung cancer in C57BL
mice), the tumor uptakes of intravenously administered PEGylated SWNTs were 8
%ID/g and 9 %ID/g, respectively,87 considerably higher than those for SWNTs without
covalent PEGylation (in the absence of any specific targeting moieties).90
Despite the experimental demonstration on the efficiency of carbon nanotubeenabled or associated delivery, the cell uptake mechanism and pathway of such delivery
are still being debated. On the basis of the observed temperature dependent cell uptake of
carbon nanotubes, Dai and coworkers suggested an endocytosis mechanism.91-93 For
example, they used non-covalently DNA- and protein-functionalized SWNTs to study the
uptake by HeLa (adherent) and HL60 (non-adherent) cells.93 These functionalized
nanotubes were generally short (50-200 nm in length), individualized or in small bundles.
The in vitro experiments with both cell lines were consistent with the energy-dependent
endocytosis mechanism for the internalization of these short nanotubes.93 The
internalization pathway could be mainly through clathron-coated pits instead of caveolae
or lipid rafts. They also studied the uptake of large DNA-SWNT aggregates (200-2,000
nm long and up to 15 nm wide), their results were similarly consistent with endocytosis
being the uptake mechanism. However, because of the low solubility of these micro-scale
nanotube aggregates, the uptake pathway was largely unclear.93
The group of Kostarelos, Prato, and others disagreed with the endocytosis
mechanism and proposed instead an energy-independent non-endocytotic mechanism
involving insertion and diffusion of nanotubes through the lipid bilayer of the cell
membrane.94,95 In their mechanism, the large biomolecules used in the solubilization of
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nanotubes might alter the interactions with cells and affect the intracellular transport
kinetics of the nanotubes.94,95 To elucidate such a possibility and to study the key steps in
the cell uptake process, this group functionalized SWNTs and MWNTs on the sidewall
with a wide range of functionalities including ammonium, small fluorescent probes,
anticancer drugs, and antibiotics.95 All of these functionalized nanotubes were taken up
by a wide variety of cells, and intracellularly trafficked through different cellular barriers
into the perinuclear region, even under endocytosis-inhibiting conditions (Figure 1.8).95
These experimental results were consistent with those from molecular simulation,
supporting the hypothesis of carbon nanotubes acting as ‘nanoneedles’ to pierce or
penetrate the plasma membrane.96
The apparent disagreements on the nanotube uptake mechanism could be due in
part to differences in the nanotube constructs and the experimental procedures.95 More
specifically, the non-endocytic internalization was found for small molecules covalently
attached to carbon nanotubes, while translocation via endocytosis was found for large
bio- or aqueous soluble macromolecules-conjugated SWNTs.95 Nevertheless, mechanistic
debate is healthy and stimulating, and an improved mechanistic understanding is critical
to facilitate future development of carbon nanotube transporters for bio-delivery
applications.
Beyond the traditional delivery that relays on the cellular uptake of carbon
nanotubes, Chen et al. recently developed a MWNT-based cell nano-injector which
delivered quantum dots (QDs) into cells through physical insertion into the cell
membrane.97 Experimentally, a biotin-tethered pyrene (via a disulfide linkage) was
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Figure 1.8 (top) A scheme of SWNT–NH3+ (f-CNT 1). And the intracellular
trafficking and perinuclear localization of f-CNT 1. Triple-channel
confocal image of A549 cells incubated for 2 h (a) in the absence
(control) and (b) with 25 µg of f-CNT 1 (green). Plasma membrane
stained with dye WGA-TRITC (red) and nucleus counterstained with dye
TO-PRO3 (blue). The scale bars corresponds to 20 µm. (From Ref. [95])
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Figure 1.9 (top) Schematic of the nanoinjection procedure. And nanoinjection of QDot
streptavidin conjugates into a target HeLa cell. (A) Fluorescence image
of the cells before nanoinjection. (B) Combined bright-field and
fluorescence image of the cells before nanoinjection. The inserted arrow
indicates the target cell. The dark shape in the lower left corner is the
AFM cantilever. (C) Fluorescence image of the cells after the
nanoinjection, showing fluorescent QDot streptavidin conjugates released
inside the target cell. (D) Combined bright-field and fluorescence image
of the cells after the nanoinjection. The QDot streptavidin conjugates are
shown in red. The dark shape in the upper left corner is the retracted
AFM cantilever. In all cases, fluorescence images were acquired with λex
= 415 nm and data collection with a 655-nm filter. Images are 70 × 70
µm. (From Ref. [97])

36

synthesized and attached to MWNT-AFM tips through π-stacking. The biotinfunctionalized MWNT-AFM tips were then conjugated with steptavidin-coated QDs at a
ratio of 5-50 QDs per nanotube. The QDs were delivered into a specific cell via nanoinjection and released due to the cleavage of the disulfide bond. A major advantage
suggested for this technology was that the delivery-release process can be repeated many
times without cell damage (Figure 1.9).97

1.2.3 Bioimaging
Due to the exceptional capability of carbon nanotubes to penetrate cell
membranes as well as their other unique physical and chemical properties, there is an
increasing interest in their uses for cellular and sub-cellular imaging.98-105 There are two
major types of bioimaging with carbon nanotubes, one in the direct imaging through the
use of either the near-infrared band-gap fluorescence in semiconducting SWNTs18 or the
UV/visible emission due to passivated surface defects in functionalized SWNTs and
MWNTs;106 and the other in the indirect imaging based on associated fluorescent or
radioactive agents.
In the absence of harsh chemical treatment or alteration, the well-dispersed
semiconducting SWNTs exhibit band-gap fluorescence emissions in the near-IR spectral
region (typically 900-1,600 nm), and the fluorescent spectra are characteristic of the
chiral indices (n,m) of the specific nanotubes.18 Since most natural biomolecules are
relatively transparent and non-emissive in this spectral region, the sharp emission spectra
of SWNTs can be detected even in a complex biological environment. The band-gap
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fluorescence is quenched by surface defects in the carbon nanotubes. However, upon
oxidation and chemical functionalization of carbon nanotubes at surface defect sites, both
SWNTs and MWNTs exhibit strong photoluminescence in the visible and near-IR
spectral regions.106,107 Therefore, the well-functionalized carbon nanotubes are also
amenable to optical bioimaging applications.
Dai and coworkers used antibody-conjugated semiconducting SWNTs as near-IR
fluorescent tags for selective probing of cell surface receptors and cell imaging.105 The
SWNTs were non-covalently dispersed by phospholipid-polyethyleneglycol-amine (PLPEG-NH2). The functionalized SWNTs bearing amine groups were then conjugated with
thiolated antibodies (Rituxan and Herceptin) specific to different cell surface receptors. In
solution, these antibody-conjugated SWNTs emitted in the 1,000-1,600 nm spectral
region when excited at 785 nm, suggesting that the electronic properties of the SWNTs
were preserved after the antibody conjugation.105 The in vitro cell experiments and nearIR imaging showed specific binding of the nanotube-attached antibodies to the host cells.
The binding specificity was evaluated in terms of the fluorescence intensity ratio between
host cells and no-host cells, and the results suggested a high selectivity of 55-20:1 for
these antibody-conjugated SWNTs.105
Weisman and coworkers employed pluronic copolymer-suspended pristine
SWNTs (~1.0 nm average diameter, and ~1 µm average length) for the intracellular nearIR imaging of mouse peritioneal macrophage-like cells.98 It was found that the nanotubes
were continually uptaken by the cells (up to 7.3 µg/mL in SWNT concentration) without
any toxic effect, and that the uptake was temperature, time, and SWNT concentration
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dependent. Macrophage samples with internalized SWNTs exhibited characteristic
nanotube fluorescence spectra (Figure 1.10).98 The fluorescence intensities increased
smoothly with incubation time and external nanotube concentration. The macrophagelike cells maintained their normal behavior at a nanotube concentration of ~4 µg/mL. In
another recent study of Weisman, Beckingham, and coworkers, Drosophila melanogaster
(fruit flies) were fed with bovine serum albumin (BSA)-dispersed SWNTs.101 The
organisms and biological tissues were studied by using the intrinsic near-IR fluorescence
imaging of SWNTs. It was reported that only a very small fraction (~10-8) of the ingested
nanotubes became incorporated into the organs of the larvae.101
The visible photoluminescence (extending to the near-IR) in functionalized
carbon nanotubes is much brighter, amenable to optical bioimaging applications. A
representative example is the characteristic photoluminescence of ammonia saltsfunctionalized SWNTs (SWNT-NH3+), with the emission peak at 485 nm (corresponding
to 395 nm excitation).99 The photoluminescence was used by Lacerda et al. to visualize
the internalization and perinuclear localization of SWNT-NH3+ in human caucasian lung
carcinoma A549 cells.99 There was no cell plasma membrane damage even at a nanotube
dose up to 500 µg/mL and 24 h post-incubation. This was the first report on the UV/vis
florescence imaging of SWNTs in cells without the need of attaching a large fluorescent
label.99 By minimizing the possible alternation on nanotube surface, the method could
offer sharper images in comparison with those obtained with large fluorophore-attached
SWNTs.
For the indirect imaging with fluorescent molecules-labeled SWNTs, a represent-

39

-ative example was due to Dai and coworkers.102 They solubilized as-produced SWNTs
via sonication with fluorescein-modified polyethylene glycol (Fluor-PEG, 114 PEG
units). The absorption peak of the nanotube-attached Fluor-PEG was red shifted ~3 nm
from that of free fluorscein, and the fluorescence intensity was quenched about 67% in
phosphate buffer solution (pH 7.4). In the bio-evaluation with BT474 breast cancer cells,
substantial intracellular fluorescence was observed, suggesting cellular uptake of the
Fluor-PEG-functionalized SWNTs.102
In addition to fluorescence, radioisotope tracing (see also section 1.2.5 for more
details) and physical methods (e.g. microscopy) are also effective techniques for the
imaging of carbon nanotubes in vitro and in vivo.100,103 For example, Porter et al. directly
visualized individual SWNTs in cell through a new technique called low-loss energyfiltered transmission electron microscopy (EFTEM), which enabled the direct
determination of SWNT distribution in both stained and unstained cells.103 The nanotubes
were seen to enter the cytoplasm and localize within the cell nucleus, causing cell
mortality in a dose dependent manner.103

1.2.4 Tissue Engineering
As a result of the extended carbon-carbon sp2 network structure, carbon nanotubes
are of high mechanical strength and chemical stability.108 The Young’s modulus of
SWNTs is close to 1 TPa, and the maximum tensile strength is about 30 GPa, which
make them suitable substrates for tissue engineering.109 For example, the as-grown
MWNTs on quartz substrate from the CVD production method were used as constructs
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Figure 1.10 (top) SWNT emission spectra in an aqueous Pluronic F108 suspension
(blue trace) and in macrophage cells incubated in SWNT suspension and
then washed (red trace). Samples were excited at 660 nm. Intensities
have been scaled to aid comparison. (bottom) Fluorescence image of one
macrophage-like cell incubated with SWNTs, showing emission detected
from 1125 to 1600 nm with excitation at 660 nm. Intensities are coded
with false color, and the image was obtained from a z-axis series by
deconvolution processing. Intensity along the yellow vertical line is
plotted on the graph to the right, showing high image contrast and
localized emission sources. (From Ref. [98])
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Figure 1.11 Picture (a) shows the surgery implantation of rhBMP-2 adsorbed
MWNT/CHI scaffolds into mouse subcutaneous muscular pocket.
Optical microscope micrograph (b) shows regenerated bone tissue
and a minor fraction of remaining MWNT/CHI scaffold. Optical
micrograph (c) shows a detail of regenerated bone tissue (collagen
expressing cells, blue–green colored) after major disassembly of the
MWNT/CHI scaffold, surrounded by muscle tissue (pink colored). It
is remarkable the well-limited interface between adjacent tissues (see
black dash line). The remaining MWNT/CHI scaffold (black colored)
is pointed by black arrow. Optical micrograph (d) shows a detail of
remaining scaffold plenty of fibroblasts (purple colored), prior to its
disassembly and colonization by collagen expressing cells (blue–
green colored). (From Ref. [112])
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for culturing human osteoblastic cells.110 The cells were found to be successfully
attached to and grown on the MWNT constructs with higher metabolic activities than
those cultured on the control surface (highly ordered pyrolytic graphite or HOPG).
Compared to the well-spread cells cultured on HOPG, those grown on MWNTs exhibited
a spherical morphology and a disorganized cytoskeleton.110
Neural stem cells (NSC) are known for their sensitivity to the environment. Kotov
and Jan reported the differentiation of mouse embryonic neural stem cells on SWNTpolyelectrolyte multilayer thin films (PEI/SWNT, 6 layers), which were assembled layerby-layer (LBL).111 The cells were successfully differentiated to neurons, astrocytes, and
oligodendrocytes with a clear formation of neurites. Compared to the widely used polyL-ornithine (PLO) substrates, the 6-layer PEI/SWNT thin films exhibited similar
properties in terms of biocompatibility, neurites outgrowth, and the expression of neural
markers.111
Abarrategi et al. prepared a well-defined microchannel porous substrate
constructed by acid-treated MWNTs (up to 89 wt%) and chitosan (CHI).112 The in vitro
cell growth results showed that MWNT/CHI scaffolds were biocompatible for adhesion,
spreading, proliferation, and viability of C2Cl2 (myoblastic mouse) cells.112 To study the
in vivo ectopic bone formation at non-skeletal site, the rhBMP-2 (recombinant human
bone morphogenetic protein-2)-adsorbed MWNT/CHI scaffolds were implanted into the
mouse muscle tissue. After 3 weeks, the bone tissue regeneration was observed with
significant MWNT/CHI scaffold degradation and replacement by cells (Figure 1.11).112
The biocompatibility of the MWNT/CHI scaffold was confirmed by the absence of chro-
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-nic inflammation during the whole implantation period.

1.2.5 Toxicity and in vivo Biodistribution
With the rapid advances in the development of carbon nanotube-based
biomaterials and technologies, there is an urgent need for the understanding of their
toxicological and pharmacological properties. In the current knowledge, the toxicity of
carbon nanotubes depends on many factors including dosage, physical form, and
chemical modifications.12,113 For example, Cui and coworkers studied in vitro toxicity of
as-produced SWNTs in human HEK293 kidney cells.114 They found that SWNTs could
inhibit cell proliferation and at the same time decrease the cell’s ability to adhere in a
dose and time-dependent manner. However, the observed toxicity of the pristine SWNTs
might be due to the lack of water solubility and the metal contamination, as debated in
different reports.115,116 For an elucidation of these issues, Isobe et al. prepared a metalfree and water-soluble carbon nanohorn aggregate (NHA) to simulate the covalently
bonded class of self-aggregated carbon nanotubes.116 The cytotoxicity study of the NHA
on 3T3 and HeLa cell lines showed a very low cytotoxicity, even lower than that of the
widely used quartz microparticles, though there were still doubts on the reliability of the
results because of some experimental problems.116
In general, carbon nanotubes upon chemical modification exhibit much less
toxicity or non-toxicity to living cell lines that have been investigated so far.117,118 For
instance, Dumortier et al. conducted in vitro cell uptake study of the functionalized
SWNTs with B and T lymphocytes and macrophages.117 Two types of functionalized
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SWNTs were used, one prepared via 1,3-dipolar cycloaddition reaction and the other
obtained through oxidation/amidation treatment. Both types of the functionalized
nanotubes were rapidly uptaken by lymphocytes and macrophages without affecting the
overall cell viability, and the one functionalized through the cycloaddition (thus higher
water solubility) was found not affecting the functional activity of the different types of
immunoregulatory cells.117
Carbon nanotubes may enter the body via the route of intravenous, dermal,
subcutaneous, inhalational, intraperitoneal, or oral.119 The potential in vivo toxicity of
carbon nanotubes has been reported and discussed.12 Largely preliminary in vivo toxicity
studies on respiratory and skin exposure to pristine carbon nanotubes did show some
harmful effects.120,121 In a recent study reported by Donaldson and coworkers,122 pristine
and BSA-dispersed MWNTs were intraperitoneal injected into mice at a dose of 50 µg
per mice. Only the long pristine MWNTs (more than 20 µm in length) showed some
pathogenic effects similar to the foreign body inflammatory response caused by long
asbestos (Figure 1.12).122 Conclusive results on the long-term exposure to these
commercially supplied long MWNTs are still needed.
Gambhir and coworkers also conducted a pilot toxicologic study of the covalently
and non-covalently PEG-functionalized SWNTs in mice.123 Their results suggested that
the functionalized SWNTs persisted within liver and spleen macrophages for 4 months
without apparent toxicity.123
In the in vivo experiments on pristine and the PEGylated SWNTs in mice, Yang et
al.87,88 did not find any of the animals exhibiting any signs of acute toxicity response

45

during the experimental period, even at a high exposure of 80 mg pristine or 24 mg
PEGylated SWNTs (nanotube equivalent, both skeleton 13C-enriched) per kilogram body
weight, consistent with other reports.
A systematic and quantitative analysis of metabolic process for carbon nanotubes
in living body, such as their degradation, distribution, clearance, and bioaccumulation, is
mandatory in order to fully understand their in vivo toxicity. Again according to the
studies by Yang et al., the

13

C-enriched pristine SWNTs were cleared from the

bloodstream quickly and distributed throughout most of the organs within 24 h (Figure
1.13).88 The nanotubes primarily accumulated in the lungs, liver, and spleen and retained
at the relatively high accumulation levels over 28 days. Most noticeably and interestingly,
there was around 1-3%ID accumulation of SWNTs in the brain, suggesting that the
nanotubes could overcome the blood brain barrier. While the accumulation level of
SWNTs in liver was relatively constant, there was a gradual decrease in the lungs from
15%ID to 9.4%ID in the monitoring period, for which the secretion by alveolar
macrophage as mucus through mucociliary transport and the translocation through lymph
nodes were suggested as pathways for the clearance of the SWNTs from lungs.88 Differ
from their modified/functionalized counterparts,87 these pristine SWNTs could hardly be
detected in urine and feces by either

13

C isotope ratio measurements or transmission

electron microscopy (TEM) analyses, suggesting that the nanotube morphology along
with surface functionalities might significantly affect the nanotube in vivo behaviors.88
The PEGylated SWNTs were found to have the similar biodistribution profile to that of
the pristine ones, with a rapid distribution time frame of ~ 1 h and also significant accum-
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Figure 1.12 Effect of the fibre on diaphragms after 7 days. a, TEM images of the test
samples, NTtang2 : low-aspect-ratio tangled MWNT aggregates, LFA:
long-fibre amosite, and NTlong1 : MWNTs with a substantial portion
longer than 20 µm. Female C57Bl/6 mice were injected i.p. with 50 µg of
sample, killed after 7 days, and the diaphragms excised and prepared for
visualization. b,c, SEM images (b) and haematoxylin and eosin histology
sections (n = 3) (c) of the diaphragms show the presence of
granulamatous inflammation (GI) in mice exposed to LFA, NTlong1. A
small granuloma response in one of the three mice treated with NTtang2
was observed. The muscular portion of the peritoneal diaphragm (PD)
and the mesothelial layer (ML) are aligned to show granulomatous
inflammation at the peritoneal aspect of the diaphragm surface. Scale
bars in b: 200 µm. Scale bars in c: 50 µm. (From Ref. [122])
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Figure 1.13 The biodistribution of pristine SWNTs (skeleton 13C-enriched) in mice
at different time points post-exposure. Data are presented as the mean
± SD (n = 3). (From Ref. [88])
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-ulation in liver and spleen.87 At day 7 post exposure, for example, ~25%ID and ~3%ID
of the PEGylated SWNTs remained in liver and spleen, respectively. Nevertheless, the
uptake of the PEGylated SWNTs by reticuloendothelial system (RES) was significantly
reduced (28%ID)87 in comparison with the pristine SWNTs (37%ID).88
Radiotracing is an efficient and broadly adopted method for in vivo visualization
of functionalized carbon nanotubes. The radio-labeling surface functionalities with 125I,124
111

In,100,104

64

Cu,90

99m

Tc,125 and

14

C,126 has made it possible to quantitatively map the

location of carbon nanotubes inside aminals at different doses and time points. In a study
by Singh et al., SWNTs were sidewall functionalized with

111

In chelated

diethylentriaminepentaacetic ([111In]DTPA) and were intravenously administered into
mice.100 The conjugates were rapidly cleared from systemic blood circulation with a halflife of ~3 h through renal excretion route, and no retaining was found in any of the RES
organs (liver and spleen).100 The same functionalization strategy was later transferred to
the preparation of [111In]DTPA-labeled MWNTs.104 After the injection into the mice
through tail vein, the dynamic radioactivity tracking of the [111In]DTPA-MWNT showed
that the nanotubes quickly entered systemic blood circulation and started their
accumulation in kidney and bladder within 60 seconds. At 24 h, almost all MWNTs were
eliminated from the body, and only a trace amount of radioactivity was detected in the
kidney (Figure 1.14).104 The bio-distributions of DTPA-functionalized MWNTs (DTPAMWNT) and serum-coated purified MWNTs were also compared by using the traditional
histological examination of the major organs 24 h after the mice were intravenously
administrated. The purified MWNTs exhibited accumulation in lung and liver, while no
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such accumulation was found for DTPA-MWNT, consistent with the dynamic
radioactivity tracking results obtained with [111In]DTPA-MWNT.104
Similarly, Dai and coworkers investigated the biodistribution and tumor targeting
ability of HiPco-produced SWNTs wrapped with radio-labeled (64Cu) phospholipid
polyethylene-glycol copolymers (PL-PEG) in mice by in vivo positron emission
tomography (PET), ex vivo biodistribution analysis, and Raman spectroscopy.90 They
found that the PL-PEG-functionalized SWNTs were surprisingly stable in vivo,
exhibiting relatively long blood circulation time and low RES uptake. Efficient targeting
of integrin positive tumor in mice was also demonstrated by tethering PL-PEG chains
with RGD peptides (recognizing integrin positive tumors).90
Radioactive elements have been conjugated to carbon nanotubes usually through
chelation with surface functionalities. Such conjugates could suffer from decreasing or
even losing activity over time due to gradual decay or dissociation of radiolabel from
carbon nanotubes. Therefore, direct detection techniques based on the intrinsic physical
properties of carbon nanotubes, such as Raman and near-IR fluorescence, might be more
advantageous in the monitoring of their in vivo behaviors in both short and long terms.
For example, the non-covalently PL-PEG (both linear and branched)-functionalized
SWNTs were intravenously injected into mice for the study of their blood circulation and
long-term fate in terms of the nanotubes’ intrinsic Raman signatures (Figure 1.15).89
Effective PEG coating (longer chain and branched structure) on SWNTs afforded longer
blood circulation, lower RES uptake, and near-complete clearance from main organs via
biliary and rental pathways in ~2 months, which was likely due to their improved
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Figure 1.14 (top) A scheme of [111In]DTPA-MWNT. Normal rat distribution of
[111In]DTPA-MWNT. a) Dynamic anterior planar images of whole
body distribution of [111In]DTPA-MWNT within 5 min after
intravenous administration in rats. Color scale for radioactivity levels
shown in arbitrary units. b) Static anterior planar images of whole body
distribution of [111In]DTPA-MWNT in rats after 5 min, 30 min, 6 h,
and 24 h post-injection (difference between a, 0–299 s image and b, 5
min image is due to lag-time in camera setup). c) % ID radioactivity
per gram tissue at 24 h after intravenous administration of
[111In]DTPA-MWNT quantified by gamma counting (n = 3 and error
bars for standard deviation). (From Ref. [104])
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Figure 1.15 (top) A scheme of functionalized SWNTs by various phospholipid-PEGs.
And SWNTs in mice tissues probed by ex vivo Raman spectroscopy after
injection into mice. (a) At 1 day p.i., biodistribution of SWNT-l-2kPEG,
SWNT-l-5kPEG, and SWNT-br-7kPEG samples. (b and c) Evolution of
the concentrations of SWNTs retained in the liver and spleen of mice
over a period of 3 months. SWNT-l-2kPEG exhibited highest
concentrations of retained SWNTs.(d) Raman mapping images of liver
slices from mice treated with SWNT-l-2kPEG (Left), SWNT-l-5kPEG
(Center), and SWNT-br-7kEG (Right) at 3 months p.i. Again, highest
SWNT Raman signals were observed in the SWNT-l-2kPEG-treated
mouse sample under the same Raman imaging conditions (laser power,
beam size, etc.). The error bars in a–c were based on three to four mice
per group. Note that the injected SWNT solutions had a concentration of
0.1 mg/mL (optical density was 4.6 at 808 nm for 1 cm path). (From Ref.
[89])
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hydrophilicity and resistance to protein nonspecific binding.89
Similarly, Cherukuri et al. used the near-IR fluorescence of individualized
semiconducting SWNTs to study their blood elimination kinetics and biodistribution in
rabbits.127 The pluronic copolymer-coated SWNTs were intravenously administered into
rabbits at a dose of ~20 µg SWNT per kg body mass. The pluronic coating was found to
be displaced by blood protein within seconds, as indicated by changes in the near-IR
emission spectra. The nanotube concentration in the blood serum decreased exponentially
with a half-life of 1 h, and no adverse effects were observed in terms of the rabbit
behavior and the pathological examination. At 24 h post administration, significant
concentrations of nanotubes were found only in the liver.127
It seems that based on the available in vivo biodistribution and toxicity studies
there is no good evidence suggesting any significant acute toxicity or negative health
effects of carbon nanotubes on the animals involved in the experiments. Obviously,
further investigations are necessary and are likely already in progress in many
laboratories to better address the toxicity and related issues.

1.3 Conclusions and Perspectives

The gradually maturing research topic concerning the chemical modification and
functionalization of carbon nanotubes has stimulated the proliferation of studies on their
potential bioapplications. Here we have reviewed the recent advances in the modification
and functionalization of carbon nanotubes by biomolecules (e.g. proteins, DNAs, and
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carbohydrates). Upon the modification and/or functionalization, the toxicological impacts
of carbon nanotubes are significantly reduced, offering great opportunities to the use of
carbon nanotubes for diagnostic and therapeutic purposes. Many experimental
investigations have demonstrated that carbon nanotubes are ideal scaffolds to
carry/display multiple biomolecules or bioactive species for applications such as
capturing pathogens, substance delivery, bioimaging, and high-performance biosensors.
Carbon nanotubes currently represent one of the most promising platforms for
novel biomaterials, though many technological challenges have to be overcome in order
to realize their full potentials. For example, the performance of carbon nanotube-based
biosensors depends strongly on the nanotube structural and electrical properties, so that
the patterned growth and controlled deposition of nanotubes at desired sites with defined
structures are necessary for more effective biosensing. The establishment of more
accurate mechanisms for the interactions of carbon nanotubes with cells and other
biological species is fundamentally important to the development of carbon nanotubebased bio-nanotechnologies. Along the same line, in-depth and systematic studies of
pharmacokinetic profiles and long-term in vivo toxicity of carbon nanotubes are critical to
their eventual clinical applications and therefore must be vigorously and carefully
pursued. Nevertheless, the obviously rapid advances in this field have led us to conclude
that there is a bright future for carbon nanotubes in biology and medicine.
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CHAPTER II
SUGAR-FUNCTIONALIZED CARBON NANOTUBES
AND BIOAPPLICATIONS

2.1 Overview

Single-walled and multiple-walled carbon nanotubes (SWNTs and MWNTs,
respectively) have attracted much attention for their exceptional physical and chemical
properties, and ever since their discovery for potential biological and biomedical
applications. As reviewed in chapter I, recent advances in these applications include the
use of carbon nanotubes as highly sensitive nanoscale biosensors, and as bio-carriers for
drug or gene delivery and specific cell recognition. In this chapter, we report our
contribution to this field, specifically the use of carbon nanotube as unique scaffold to
display multivalent sugars in solution for various biological applications.
We functionalized SWNTs with tethered galactoses for aqueous solubility and for
the nanotube-bound multivalent carbohydrate ligands to bind specifically to pathogenic
Escherichia coli in solution to result in the significant cell agglutination (section 2.2). We
extended our study to use dendritic molecules with paired galactoses to functionalize
MWNTs, which offer advantages such as more economical production, higher purity, and
larger inner tubular cavity (section 2.3). We then explored more systematically the use of
carbon nanotubes to display multiple sugar moieties in pairs and in quartets, including the
synthesis of a series of dendritic galactopyranosides and mannopyranosides with a
terminal amino group for their functionalization of carbon nanotubes (section 2.4). These

sugar dendron-functionalized nanotube samples were thoroughly characterized and
evaluated in biological assays such as the binding with pathogenic E. coli and with
Bacillus subtilis (a nonvirulent simulant for Bacillus anthracis or anthrax) spores (section
2.4).
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2.2 Single-Walled Carbon Nanotubes Displaying Multivalent
Carbohydrate Ligands for Capturing Pathogens
2.2.1 Introduction
There have been considerable scientific interests in the understanding and
mimicking of bacterial adhesin-specific interactions for various purposes, such as
pathogen detection and the inhibition of bacterial infections via the chemotactic
responses of the bacteria toward the corresponding ligands.1,2 Both natural and synthetic
multivalent inhibitors have been evaluated.1 The latter includes the use of linear and
branched polymers,3 dendrimers,4 proteins,5 polymeric and other nanoparticles,6,7 etc. to
display multiple copies of sugar moieties.
Single-walled carbon nanotubes (SWNTs) represent a unique class of onedimensional nanostructures, which offer many properties that are not available in
traditional polymeric materials and nanoparticles.8 Potential biological applications of
carbon nanotubes have been discussed and explored.9,10 Among widely investigated have
been the uses of the nanotubes in nanoscale biosensors.10-12 Most of these applications
require chemical modifications or functionalization of the nanotubes to impart aqueous
solubility and/or to introduce biofunctionalities.10 In fact, carbon nanotubes have been
functionalized with a variety of bioactive groups,9-16 and the functionalized carbon
nanotubes have allowed the studies of their interactions with biological species.17,18 These
studies are not only important fundamentally but also critical to the development of
practical biosensors.
Because of the versatile chemical modification and solubilization, the one-

dimensional nanostructure of a SWNT, with the high surface area-to-weight ratio and
some structural flexibility, may be exploited as a platform for multivalent array of
carbohydrates in solution under physiological conditions. Here we report that SWNTs
can be solubilized via the functionalization with derivatized galactoses and that the
nanotube-bound galactoses could serve as polyvalent ligands and thus strongly interact
with receptors on pathogenic E. coli, resulting in significant cell agglutination (Scheme
2.2.1).

2.2.2 Experimental Section
2.2.2.1 Materials
Palladium (10 wt% on activated carbon), 1-[3-(dimethylamino)propyl]-3ethylcarbodiimide hydrochloride (EDAC), and amberlite IR-120 (plus) ion-exchange
resin were purchased from Sigma-Aldrich. 18-crown-6, ß-D-galactose-pentaacetate, α-Dmannose, pyridine, and anthrone were obtained from Acros. Sodium azide (99%) were
from Alfa Aesar, tetrabutylammonium bromide (98%) was from Lancaster, and ethanol,
chloroform, methylene chloride, THF, DMF, and diethyl ether were from Fisher. Solvent
grade THF was dried and distilled over molecular sieves and then distilled over sodium
before use. Other solvents were either spectrophotometry/HPLC grade or purified via
simple distillation. Deuterated NMR solvents were obtained from Cambridge Isotope
Laboratories.
The SWNT sample was produced in Prof. A. M. Rao’s laboratory (Physics
Department, Clemson University) by using the arc-discharge method. It was purified by
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Scheme 2.2.1 A schematic illustration for Gal-SWNT caused E. coli cell agglutination.
.
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oxidative acid treatment. In a typical experiment, a nanotube sample (1 g) was added to
an aqueous HNO3 solution (2.6 M), and the mixture was refluxed for 48 h. Upon
centrifuging at 1380g (Fisher scientific, centric 228 centrifuge) to discard the supernatant,
the remaining solids were washed with deionized water until neutral pH and then dried
under vacuum.

2.2.2.2 Measurements
NMR measurements were carried on a JEOL Eclipse +500 NMR spectrometer
and a Bruker Advance 500 spectrometer that is equipped with a high-resolution magicangle-spinning (HR-MAS) probe designed specifically for gel-phase NMR. The residual
proton and carbon resonance of the deuterium solvents were used as internal standards.
MALDI-TOF MS was performed on a Bruker AutoFlex system, with 2,5dihydroxybenzoic acid as the sample matrix. Optical absorption spectra were recorded on
a Shimadzu UV3600 UV-VIS-NIR spectrophotometer. Thermo gravimetric analysis
(TGA) was carried out on a Mettler-Toledo TGA/SDTA851e system. Raman spectra
were obtained on a Johin Yvon T64000 spectrometer equipped with a Melles-Griot
35mW He: Ne laser source for 632.8nm excitation, a triple monochromator, a research
grade Olympus BX-41 microscopy and a liquid nitrogen-cooled symphony detector.
Scanning electron microscopy (SEM) images were obtained on a Hitachi S4700 fieldemission SEM system. Atomic force microscopy (AFM) analysis was conducted on a
Molecular Imaging PicoPlus system equipped with a multipurpose scanner. The height
profile analyses were assisted by using the SPIP software distributed by Image
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Metrology.
The spectrophotometric method with the use of anthrone reagent was used to
determine sugar contents.19 In a typical experiment, a solution of sugar-functionalized
SWNTs (50 µL) was mixed with deionized water (50 µL), HCl (37%, 1 mL), formic acid
(0.1 mL) and anthrone reagent (8 mL, 0.2 mg/mL in 80% H2SO4). The solution mixture
was kept in a boiling water bath for 12 min, and then rapidly cooled in an ice bath for 30
min. The UV/vis absorption of the mixture was measured and corrected. Separately, the
standard sugar (β-D-galactose or α-D-mannose) solutions of known concentration (1.0
mg/mL) were prepared. Various aliquots of the standard solutions (0, 25, 50, 75, and 100
µL) were tested in terms of the same procedure above to establish standard curves, from
which the sugar content in the functionalized nanotube sample was obtained.

2.2.2.3 Synthesis of Sugar Monomers
The sugar monomers (Gal- and Man-) were synthesized in terms of procedures20
shown in Scheme 2.2.2 and 2.2.3.
2-Chloroethyl-2,3,4,6-tetra-O-acetyl-β-D-galactopyranoside (1). To a cold
solution (0 ºC) of β-D-galactose-pentaacetate (7.8 g, 20 mmol) and 2-chloroethanol (1.93
g, 24 mmol) in dry CH2Cl2 was added BF3.OEt2 (48% Et2O solution, 15 mL, 120 mmol)
dropwise. Reaction mixture was gradually warmed to rt and stirred for 12 h before
washed with cold water (10 mL × 3), aqueous sodium bicarbonate (5%, 10 mL), and cold
water (10 mL). The organic phase was dried over anhydrous MgSO4. Filtrate was
condensed on a rotary evaporator. Crude product was purification by column
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chromatography on silica gel with eluent of ethyl acetate : hexane (1:1) to afford 1 as a
colorless solid (7.5 g , 91%): 1H NMR (500 MHz, CDCl3) δ 5.39 (d, J = 3.65 Hz, 1H),
5.22 (q, 1H), 5.02 (dd, 1H), 4.53 (d, J = 8.25 Hz, 1H), 4.20-4.16 (m, 1H), 4.15-4.09 (m,
2H), 3.91 (t, 1H), 3.78-3.73 (m, 1H), 3.64-3.61 (t, 2H), 2.15 (s, 3H), 2.07 (s, 3H), 2.05
(s, 3H), 1.98 (s, 3H); 13C NMR (125.7 MHz, CDCl3) δ 170.5, 170.3, 170.3, 169.7, 101.7,
70.9, 70.8, 70.1, 68.6, 67.0, 61.3, 42.6, 20.9, 20.8, 20.8, 20.7 ppm. MALDI-TOF MS
(M+Na)+ : 433.88.
2-Azidoethyl-2,3,4,6-tetra-O-acetyl-β-D-galactopyranoside (2). Sodium azide
(5.6 g, 80 mmol) was added to a mixture of 1 (7.5 g, 18 mmol) and 18-crown-6 (100 mg,
0.37 mmol) in DMF (30 mL). The system was stired at 65 ºC for 24 h. Water (60 mL)
and toluene (120 mL) were added, organic layer was dried, condensed, and purified by
column chromatography on silica gel with the eluent of ethyl acetate : hexane (1:1.5) to
yield 2 (6.5 g, 86% ): 1H NMR (500 MHz, CDCl3) δ 5.37 (dd, 1H), 5.23-5.19 (t, 1H),
5.01-4.99 (dd, 1H), 4.53 (d, J = 7.75 Hz, 1H), 4.19-4.09 (m, 2H), 4.04-4.00 (m, 1H),
3.92-3.88 (m, 1H), 3.70-3.64 (m, 1H), 3.51-3.45 (m, 1H), 3.30-3.25 (m, 1H), 2.13 (s,
3H), 2.04 (s, 3H), 2.02 (s, 3H), 1.95 (s, 3H);

13

C NMR (125.7 MHz, CDCl3) δ 170.5,

170.3, 170.2, 169.6, 101.2, 70.9, 70.8, 68.6, 68.5, 67.1, 61.3, 50.6, 20.8, 20.7 (2C), 20.6
ppm. MALDI-TOF MS (M+Na)+ : 438.85.
2-Azidoethyl-β-D-galactopyranoside (Gal-N3). 2 (2.085 g, 5 mmol) was
dissolved in 200 mL NaOCH3 (0.1 M) and stirred at room temperature for 24 h. After
concentration, the resulting residue was dissolved in water (50 mL) and then neutralized
by Amberlite resin. The solvent was removed on a rotary evaporator to give Gal-N3
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quantitatively: 1H NMR (500 MHz, MeOH-d4) δ 4.27-4.25 (dd, 1H), 4.04-3.99 (m, 1H),
3.83-3.81 (dd, 1H), 3.78-3.69 (m, 3H), 3.52 (m, 2H), 3.47 (m, 3H);

13

C NMR (125.7

MHz, MeOH-d4) δ 105.2, 76.8, 75.0, 72.5, 70.3, 69.3, 62.5, 52.1 ppm. MALDI-TOF MS
(M+Na)+ : 272.73.
1,2,3,4,6-Penta-O-D-acetyl mannopyranoside (3). A solution of D-mannose
(15.0 g, 83.3 mmol) in anhydrous pyridine (70 mL) was placed in an ice bath, followed
by dropwise addition of acetic anhydride (100 mL, 1058.8 mmol). The mixture was
stirred at 0 °C for 1 h and then at room temperature for 12 h. Pyridine and excess acetic
anhydride were removed on a rotary evaporator, and chloroform (70 mL) was added. The
mixture was washed with cold water (10 mL each for 3 times), aqueous sodium
hydrogencarbonate (5%, 10 mL), and again cold water (10 mL). The organic fraction was
dried over anhydrous MgSO4. After filtration, the solvent was removed on a rotary
evaporator to yield 3 (29.2 g, 90% yield): 1H NMR (500 MHz, CDCl3) δ 6.08 (d, J =
1.85 Hz, 1H), 5.1-5.5 (m, 3H), 4.2-4.4 (m, 1H), 4.0-4.2 (m, 2H), 2.0-2.3 (m, 15H);

13

C

NMR (125.7 MHz, CDCl3) δ 170.5, 169.9, 169.7, 169.6, 168.0, 90.5, 70.5, 68.7, 68.3,
65.4, 62.0, 20.0-22.0(m) ppm.
2-Chloroethyl-2,3,4,6-tetra-O-acetyl-α-D-mannopyranoside (4). To a cooled
(ice-water), solution of III (13.5 g, 34.6 mmol) and 2-chloroethanol (4.18 g, 51.9 mmol)
in anhydrous dichloromethane (60 mL) was added (with stirring) BF3-etherate (22 mL,
173 mmol) dropwise. The mixture was stirred at 0 °C for 1 h, and then at room
temperature for 12 h. The same procedure described above for 3 was used in the workup
to yield 4 (12.7 g, 90% yield): 1H NMR (300 MHz, CDCl3) δ 5.22-5.37 (m, 3H), 4.89 (d,
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N3

J = 1.42 Hz, 1H), 4.25-4.35 (m, 1H), 4.00-4.16 (m, 2H), 3.80-3.97 (m, 2H), 3.70 (t, J =
5.54 Hz, 2H), 2.0-2.3 (m, 12H);

13

C NMR (75.4 MHz, CDCl3): δ 170.5, 169.9, 169.8,

169.7, 97.7, 69.3, 68.9, 68.5, 67.1, 65.9, 62.3, 42.4, 20.0-22.0 (m) ppm.
2-Azidoethyl-2,3,4,6-tetra-O-acetyl-α-D-mannopyranoside (5). To a solution of
4 (12.7 g, 30.9 mmol) and tetrabutylammonium bromide (0.2 g, 0.6 mmol) in DMF (50
mL) was added sodium azide (20 g, 309 mmol). The mixture was kept at 65 °C for 12 h.
DMF was removed on a rotary evaporator, and the sample was re-dissolved in
chloroform (50 mL). The organic phase was washed by water (10 mL each for 3 times)
and dried over anhydrous MgSO4. After filtration, the solvent was removed to yield 5
(12.6 g, 98% yield): 1H NMR (500 MHz, CDCl3) δ 5.28-5.40 (m, 3H), 4.90 (d, J = 1.41
Hz, 1H), 4.30 (m, 1H), 4.10 (m, 2H), 3.88 (m, 1H), 3.70 (m, 1H), 3.47 (m, 2H), 1.9-2.3
(m, 12H); 13C NMR (125.7 MHz, CDCl3) δ 170.7, 170.0, 169.9, 169.8, 97.7, 69.4, 68.9,
68.8, 67.1, 66.0, 62.5, 50.4, 20.0-22.0 (m) ppm.
2-Azidoethyl-α-D-mannopyranoside (Man-N3). 5 (5.0 g, 12 mmol) was
dissolved in CH3ONa/CH3OH (0.1 M, 500 mL) and stirred at room temperature for 24 h.
After being concentrated, the resulting residue was dissolved in water (100 mL) and then
neutralized by Amberlite resin. The solvent was removed on a rotary evaporator to yield
Man-N3 quantitatively: 1H NMR (500 MHz, D2O) δ 4.89 (d, J = 1.85 Hz, 1H), 3.95 (m,
1H), 3.84-3.93 (m, 2H), 3.80-3.83 (m, 1H), 3.60-3.78 (m, 4H), 3.40-3.56 (m, 2H);
NMR (125.7 MHz, D2O) δ 100.0, 73.1, 70.5, 70.1, 66.8, 66.5, 61.1, 50.3 ppm.

2.2.2.4 Nanotube Functionalization
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13

C

Before the functionalization reaction, Gal-N3 and Man-N3 were reduced to GalNH2 and Man-NH2 by the classical palladium-catalyzed hydrogenation. At 0 ºC, to a
solution of Gal-N3 or Man-N3 (2.085 g, 4 mmol) in methanol (10 mL) was added Pd/C
(10 wt% palladium on activated carbon, 200 mg). The reaction mixture was gradually
warmed to room temperature and stirred with the purging of hydrogen gas for 4 h. The
Pd/C was removed by filtration, and the filtrate was evaporated to obtain Gal-NH2 or
Man-NH2.
The functionalization of SWNTs was based on the carbodiimide-activated
amidation of the galactose-tethered amino groups with the nanotube-bound carboxylic
acids.21 In a typical reaction, a purified SWNT sample (45 mg) was mixed with 1-ethyl-3(3-dimethylaminopropyl) carbodiimide (EDAC, 112 mg, 60 mmol) in aqueous KH2PO4
buffer (45 mL, pH = 7.4). Upon activation via sonication for 2 h, Gal-NH2 or Man-NH2
(450 mg, 2 mmol) was added. After sonication for another 36 h, the reaction mixture was
loaded into a membrane tubing (cutoff molecular weight ~ 12,000) for dialysis against
fresh deionized water for 3 days. The resulting suspension was centrifuged (1,380 g) for
30 min, yielding a dark-colored homogeneous aqueous solution of the galactose functionalized SWNTs (Gal-SWNT) or mannose-functionalized SWNTs (Man-SWNT).
Gal-SWNT: 1H NMR (500 MHz, D2O) δ 4.1-4.0 (broad), 4.0-3.8 (broad), 3.8-3.6
(broad), 3.6-3.5 (broad) ppm.
Man-SWNT: 1H NMR (500 MHz, D2O) δ 4.1- 4.0 (broad), 4.0-3.7 (broad), 3.7-3.5
(broad) ppm.
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2.2.2.5 Assay for E. coli
The E. coli O157:H7 strain C7927 was kindly provided by Prof. Michael P.
Doyle, University of Georgia. After growth, repeated washing, and separation via
centrifuging, the E. coli cells were suspended in sterile saline solution (0.85% NaCl) to
an optical density of 0.5 (~5 x 108 CFU/mL according to McFarland standard #2). An
aliquot of the suspension (200 µL) was added to an aqueous solution of the Gal-SWNT
(0.32 mg/mL, 0.1 mL), and the mixture was rotated (40 rpm) at room temperature for 1 h.
Upon centrifuging at 14,000 g (Eppendorf 5417R), the supernatant was discarded and the
pellet was washed with phosphate bufferred saline (PBS) via the same centrifugingsuspending procedure twice. The final pellet was suspended in a gluteraldehyde solution
(1 mL 2.5% gluteraldehyde in 0.2 M sodium cacodylate - hydrochloric acid buffer, pH
7.5) for fixing at room temperature for 30 min. The suspension was collected on a
polycarbonate filter (Whatman nucleopore 0.2 µm) and allowed to fix for another 30 min.
The filter with the specimen was rinsed with the sodium cacodylate - hydrochloric acid
buffer (shaking for 5 min) 3 times, followed by post-fixing with freshly prepared osmium
oxide solution (1%, enough to cover the filter) for 1 h. Upon repeated rinsing with
double-distilled water (shaking for 5 min each time), the specimen was dehydrated with
graded ethanol and shaken: 50% for 30 min, 75%, 85%, and 95% each for 10 min, and
100% for 10 min twice. The specimen was subjected to critical point drying to remove
the ethanol completely, and was then mounted onto an aluminum stub with double-sided
carbon tape for platinum coating before the electron microscopy analysis.
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2.2.3 Results and Discussion
The Gal-SWNT sample was characterized by a series of instrumental techniques
including solution-phase NMR, scanning and transmission electron microscopy (SEM
and TEM), Raman, and near-IR optical absorption. The NMR results suggested
significant effect on the galactoses from the nanotube attachment, consistent with the
expected covalent functionalization. The SEM and TEM results showed that the
nanotubes were exfoliated and well-dispersed (Figure 2.2.1). The Raman and near-IR
absorption spectra were also typical of solubilized SWNTs. For example, the S11 (1,828
nm) and S22 (1,035 nm) absorption bands associated with the van Hove singularity pairs
were preserved in the Gal-SWNTs (Figure 2.2.2).22 The nanotube content in the sample
was estimated to be about 30% (wt/wt) in terms of the thermogravimetric analysis
(TGA), in which the galactose functionalities were thermally defunctionalized and
removed from the nanotube surface.23 On the other hand, the Gal-SWNTs in aqueous
buffer was tested for total sugar content in terms of the classical spectrophotometry with
the anthrone reagent.19 The result thus obtained (65 wt% sugar, with the rest being
primarily nanotubes) in reference to the galactopyranoside before nanotube
functionalization is in reasonable agreement with the TGA estimate of nanotube content.
Shown in Figure 2.2.3 are typical SEM images of the specimen of Gal-SWNT
interact with E. coli O157:H7. There are apparently strong interactions between GalSWNTs and the pathogenic E. coli cells, with multiple nanotubes binding to one cell and
some nanotubes “bridging” adjacent cells to result in significant agglutination.
The observed binding in Figure 2.2.3 is specific to the Gal-SWNTs. In the control
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experiments, SWNTs covalently functionalized with either α-D-mannose or bovine
serum albumin (BSA) protein16 and thus similarly soluble in aqueous PBS buffer were
used to replace Gal-SWNTs under otherwise essentially the same experimental
conditions, but no apparent binding was observed (Figure 2.2.4). This suggests that the
nanotube-bound galactoses in Gal-SWNTs were responsible for the binding and cell
agglutination shown in Figure 2.2.3. This is consistent with the report that there are
periplasmic galactose-binding proteins on the E. coli cell surface to couple with galactose
ligands.24
Multivalent ligands carried on polymers, dendrimers, or proteins are known to
be more potent than their monovalent counterparts in cell adhesion.25 For the GalSWNTs in this study, the high aspect ratio and large surface area of the nanotubes enable
the display of abundant sugar arrays, which are excellent polyvalent ligands toward the
specific receptors on the cell surface. The semi-flexible nature of the nanotube scaffold
may also facilitate the binding of multiple galactose ligands with the E. coli cell.

2.2.4 Summary
In summary, the results reported here suggest that SWNT could serve as a unique
carrier for multiple carbohydrate ligands and that the Gal-SWNTs are highly efficient in
the capturing of pathogenic E. coli in physiological solutions. The same materials may be
applied to other pathogens bearing galactose receptors. In addition, the aqueous soluble
SWNTs displaying galactoses and other bioactive ligands may also be developed as
potent inhibitors or effectors for specific cellular responses.
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a

b

Figure 2.2.1 (a) SEM image and (b) HR-TEM image (scale bar = 10 nm)
of Gal-SWNT.
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Figure 2.2.2 Near-IR absorption spectrum of Gal-SWNT.
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Figure 2.2.3 SEM images for Gal-SWNT capturing pathogenic
E. coli cells. (Courtesy of T. Elkin)
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a

b

Figure 2.2.4 SEM images from the control experiments of E. coli O157:H7
with (a) BSA-functionalized SWNTs and (b) Man-SWNT.
Other experimental procedure and conditions were kept the
same. (Courtesy of T. Elkin)
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2.3 Carbon Nanotube as Scaffold to Display Paired Sugars in Solution

2.3.1 Introduction
Single-walled (SWNT) and multiple-walled (MWNT) carbon nanotubes have
been studied extensively for their interesting and often unique properties.1 Recently, their
potential biological and biomedical applications have been attracting increasing
attention.2 For example, Kam, et al. found that protein-SWNT conjugates could be
internalized in various types of mammalian cells;3 and according to Hasegawa, et al.,
schizophyllan (a natural β-1, 3-glucan) could non-covalently wrap around SWNTs, with
the pendant lactoside functional groups on schizophyllan still available for specific lectin
recognition.4 It has also been shown that the one-dimensional nanostructure of a nanotube
could be used for displaying multiple copies of bioactive species for their specific
interactions with bacterial cells,5,6 such as the use of the bovine serum albuminfunctionalized SWNTs in conjugation with Escherichia coli-specific antibody for
capturing the pathogen in physiological solution.5 In another example, Gu, et al.
solubilized SWNTs via covalent functionalization with the derivatized galactose 2’aminoethyl-β-D-galactopyranoside in likely the amidation of nanotube-bound carboxylic
acids.6 These galactose-functionalized nanotubes (Gal-SWNT), each displaying multiple
copies of the sugar, were found to have adhesion to E. coli O157:H7 to result in
significant cell agglutination.6 It is also desirable to use MWNTs for the same purpose,
not only for their more economical production and generally better purity but also for
their unique properties and related opportunities, such as their larger inner tubular

cavities allowing easier access and encapsulation of various species. However, the
functionalization of MWNTs with 2’-aminoethyl-β-D-galactopyranoside resulted in the
Gal-MWNT sample of poor aqueous solubility, hardly useful to the cell adhesion and
other biological applications in solution. An obvious difference between MWNT and
SWNT is the former being heavier, thus requiring larger and/or more extended functional
groups in the solubilization (Scheme 2.3.1). In fact, the necessary aqueous solubility
could be achieved by functionalizing MWNTs with the compound containing a galactose
pair, β-aminophthaloyl-N,N’-bis[11-O-(β-D-galactopyranosyl)-ethyl]-diamide (2, Scheme
2.3.2).

2.3.2 Experimental Section
2.3.2.1 Materials
Palladium (10 wt% on activated carbon), 1-[3-(dimethylamino)propyl]-3ethylcarbodiimide hydrochloride (EDAC), triethylamine, 5-nitroisophthaloyl dichloride,
and amberlite IR-120 (plus) ion-exchange resin were purchased from Sigma-Aldrich. 18crown-6, β-D-galactose-pentaacetate, and anthrone were obtained from Acros. Sodium
azide were from Alfa Aesar. Ethanol, chloroform, methylene chloride, THF, DMF, and
diethyl ether were from Fisher. Solvent grade THF was dried and distilled over molecular
sieves and then distilled over sodium before use. Other solvents were either
spectrophotometry/HPLC grade or purified via simple distillation. Deuterated NMR
solvents were obtained from Cambridge Isotope Laboratories.
The sample of MWNTs was supplied by Nanostructured & Amorphous Materials,
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Inc. In a typical purification procedure, the nanotube sample (1 g) was suspended and
refluxed in aqueous nitric acid solution (14%, 500 mL) for 48 h. The mixture was cooled
to room temperature and centrifuged (1,380 g, 15 min). The supernatant was discarded,
and the remaining solids were collected and washed repeatedly with deionized water until
neutral, followed by the removal of water and then drying in vacuum to obtain the
purified MWNT sample.

2.3.2.2 Measurements
NMR measurements were carried on a JEOL Eclipse +500 NMR spectrometer
and a Bruker Advance 500 spectrometer that is equipped with a high-resolution magicangle-spinning (HR-MAS) probe designed specifically for gel-phase NMR. The residual
proton and carbon resonance of the deuterium solvents were used as internal standards.
MALDI-TOF MS was performed on a Bruker AutoFlex system, with 2, 5-dihydroxybenzoic acid as the sample matrix. Optical absorption spectra were recorded on a
Shimadzu UV3600 UV-VIS-NIR spectrophotometer. Thermo gravimetric analysis
(TGA) was carried out on a Mettler-Toledo TGA/SDTA851e system. Raman spectra
were obtained on a Johin Yvon T64000 spectrometer equipped with a Melles-Griot
35mW He: Ne laser source for 632.8nm excitation, a triple monochromator, a research
grade Olympus BX-41 microscopy and a liquid nitrogen-cooled symphony detector.
Scanning electron microscopy (SEM) images were obtained on a Hitachi S4700 fieldemission SEM system. Atomic force microscopy (AFM) analysis was conducted on a
Molecular Imaging PicoPlus system equipped with a multipurpose scanner. The height
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profile analyses were assisted by using the SPIP software distributed by Image
Metrology.
The spectrophotometric method with the use of anthrone reagent was used to
determine sugar contents.7 Similar to that described in chapter 2.2, a small aliquot (50
µL) of the Gal2-MWNT solution (0.3 mg/mL) was mixed with deionized water (550 µL),
HCl (1 mL), formic acid (0.1 mL), and 80% anthrone/H2SO4 solution (8 mL). The
mixture was kept at 100 °C for 12 min, then rapidly cooled in an ice-bath for 30 min. The
corrected absorption spectrum of the mixture was obtained, and the absorbance at 625.5
nm was used against a standard curve (prepared separately under the same experimental
conditions) to determine the sugar content.

2.3.2.3 Synthesis of Galactose Dendron
The synthesis of 1 was available in chapter 2.2. The 2 (Gal2) was synthesized
in terms of procedures shown in Scheme 2.3.2.
5-Nitroisophthaloyl Dichloride: At 0 ºC, the thionyl chloride (10 mL, excess)
and DMF (10 droplet, catalytic) were added to a suspension of 5-Nitroisophthalic acid
(2.111 g, 10 mmol) in dry CH2Cl2 (15 mL). The reaction mixture was warmed to the rt.
and refluxed until a homogenous solution was developed (around 4 hrs). After refluxing
for another hour, the yellowish solution was concentrated and dried in vacuum oven for 2
hrs. The product showed up as a yellowish solid (qutitative) which can be used directly
for next step without further purification. 1H NMR (500 MHz, CDCl3) δ 9.20 (s, 2H),
9.09 (s, 1H); 13C NMR (125.7 MHz, CDCl3): 165.6, 148.9, 137.4, 136.0, 130.9 ppm.
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5-Nitroisophthaloyl-N,N’-bis[2’-O-(2,3,4,6-Tetra-O-acetyl-β-D-galactopyrano
syl) -ethyl]-diamide (I): At r.t., in a solution of CH2Cl2 (30 mL) containing 10% Pd/C
(208 mg), 2’-azidoethyl-2,3,4,6-tetra-O-acetyl-galactopyranoside (2.085 g, 5 mmol) (see
chapter 2.2) 8 was added and stirred for 4 hrs with the H2 purged in and out. The Pd/C
was filtered out and the filtrate was added triethylamine (4.5 mL) and 5-nitroisophthaloyl
dichloride (0.6 g, 2.4 mmol) at 0 °C. The mixture was stirred under nitrogen atmosphere
at 0 °C for 2hrs and further 8 hrs at r.t., then washed with 1M HCl (30mL), saturated
NaHCO3 (30 mL), and water (30 mL). The organic layer was dried and concentrated,
followed by column chromatography on silica gel with the EtOAc as the eluent to give I
as a white solid (2.04 g, 88.8%): 1H NMR (500 MHz, CDCl3) δ 8.81 (d, J = 1.35 Hz, 2H),
8.58-8.57( t, J = 1.375 Hz, 1H), 5.40-5.36 (d, J = 3.2 Hz, 2H), 5.20-5.16 (dd, J = 7.8, 7.3
Hz, 2H), 5.01-4.98 (dd, J = 3.2, 3.25 Hz, 2H), 4.50-4.49 (d, J = 7.75 Hz, 2H), 4.12-4.03
(m, 4H), 3.97-3.90 (m, 4H), 3.87-3.83 (m, 2H), 3.74-3.68 (m, 2H), 3.65-3.59 (m, 2H),
2.16 (s, 6H), 2.96 (s, 6H), 1.95 (s, 6H), 1.93 (s, 6H);
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C NMR (125.7 MHz, CDCl3) δ

170.4, 170.3, 170.1, 170.1, 164.2, 148.5, 136.3, 131.1, 124.8, 101.3, 71.0, 70.7, 69.0,
68.3, 67.0, 61.4, 40.1, 20.8, 20.7, 20.6, 20.5 ppm. MALDI-TOF-MS (M+Na+): 981.98.
5-Nitroisophthaloyl-N,N’-bis[11-O-(β–D-galactopyranosyl)-ethyl]-diamide
(II) : At r.t., compound I (1 g, 1.04 mmol) was dissolved in 0.05 M NaOMe / HOMe (15
mL) solution and stirred for 12 hrs, the white product as precipitate was filtered out and
washed with methanol. II was obtained after dried in vacuum oven (quantitative): 1H
NMR (500 MHz, D2O) δ 8.80 (s, 2H), 8.53(s, 1H), 4.44 (d, J = 7.75 Hz, 2H), 4.13-4.08
(m, 2H), 3.93-3.89 (m, 4H), 3.74-3.68 (m, 10H), 3.65-3.63 (dd, J = 3.7, 3.2 Hz, 2H), 3.55
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-3.51 (dd, J = 7.8, 7.75Hz, 2H);
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C NMR (125.7 MHz, D2O) δ 166.8, 147.7, 135.5,

131.9, 124.9, 103.0, 75.1, 72.7, 70.7, 68.6, 68.2, 60.9, 40.2 ppm. MALDI-TOF-MS
(M+Na+): 644.57.
5-Aminophthaloyl-N,N’-bis[11-O-(β–D-galactopyranosyl)-ethyl]-diamide (2,
Gal2) : At r.t., 10% Pd/C (60 mg) was added in a H2O/MeOH (3:1, 20 mL) solution of II
( 0.6 g, 1 mmol), the reaction mixture was stirred for 4 hrs with the hydrogen purged in
and out.. The Pd/C was been separated by filtering and the filtration was evaporated and
dried under vacuum to give 2(Gal2) as a colorless liquid (quantitative): 1H NMR (500
MHz, D2O) δ 7.47 (s, 1H), 7.29 (s, 2H), 4.41 (d, J = 8.25 Hz, 2H), 4.09-4.04 (m, 2H),
3.92-3.87 (m, 4H), 3.73-3.62 (m, 12H), 3.54-3.50 (m, 2H); 13C NMR (125.7 MHz, D2O)
δ 170.3, 147.3, 135.3, 117.5, 116.1, 103.1, 75.1, 72.7, 70.7, 68.6, 68.4, 60.9, 40.0 ppm.
MALDI-TOF-MS (M+Na+): 614.79.

2.3.2.4 Nanotube Functionalization
A purified MWNT sample (20 mg) was suspended in KH2PO4 buffer (pH = 7.4,
20 mL), and to the suspension was added 1-ethyl-3-(3-dimethylaminopropyl)
carbodiimide (EDAC, 180 mg, 0.94 mmol). After sonication for 1 h, 2 (496 mg, 0.84
mmol) was added, followed by sonication for another 2 h. The mixture was stirred for 36
h, and then centrifuged (1,380 g) for 30 min. The supernatant was transferred to a
membrane tubing (molecular weight cutoff ~ 12,000) for dialysis against deionized water
for 3 days. The solution from the dialysis tubing contained only a small amount of solid
residue, which was removed via centrifuging at 1,380 g for 30 min. The resulting colored
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but transparent supernatant was the solution of Gal2-MWNT (Scheme 2.3.1).

2.3.3 Results and Discussion
It is well-established that carbon nanotubes contain defect-derived carboxylic
acids after oxidative acid treatment (as a part of sample purification). These nanotubebound acid groups were targeted in amidation reactions with 1(Gal) and 2(Gal2) (Scheme
2.3.2).9 The functionalization of MWNTs with 2 resulted in a colored but transparent
supernatant which was the solution of Gal2-MWNT (Scheme 2.3.1).
The same reaction conditions were applied to the functionalization of MWNTs
with 1, but the resulting Gal-MWNT could only form an unstable aqueous suspension.
Shown in Figure 2.3.1 is a visual comparison of Gal2-MWNT and Gal-MWNT for their
different solubilities. For the comparison, the two samples in similar amounts were
dispersed in water, followed by same centrifugation. The supernatant obtained from the
Gal-MWNT dispersion is essentially colorless (Figure 2.3.1), suggesting that the sample
is hardly soluble. For Gal2-MWNT, on the other hand, the aqueous solubility was
estimated gravimetrically (by drying a fix volume of the solution) to be ~0.3 mg/mL,
which is lower than those of other water-soluble functionalized carbon nanotubes.2a,10
The solution of Gal2-MWNT in D2O was used for 1H NMR measurement. The
spectrum is compared with that of Gal2 in Figure 2.3.2. The proton signals in the
nanotube-bound Gal2 are obviously much broader, consistent with effects associated with
the low mobility of the nanotubes.9b In addition, the signals of aromatic protons in Gal2
are suppressed in the spectrum of Gal2-MWNT, which is likely due to the aromatic
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moiety being close to the nanotube surface, as already observed and discussed in the
literature on other functionalized carbon nanotubes.11,12
The Gal2-MWNT sample was characterized by various microscopy techniques,
including scanning (SEM) and transmission electron microscopy (TEM) and atomic force
microscopy (AFM). As shown in Figure 2.3.3, there are apparently abundant MWNTs of
different lengths, well-dispersed to individual nanotubes. In TEM and AFM at a high
magnification, the coating on the nanotube surface could be observed, which might
logically be attributed to the Gal2 functionalities.
In order to determine the nanotube content in the Gal2-MWNT sample,
thermogravimetric analysis (TGA) with inert gas (nitrogen) was tried to selectively
remove

the

sugar

functionalities

from

the

nanotube

surface

(or

thermal

defunctionalization9b). However, it was found that unlike Gal,6 Gal2 carbonized at high
temperatures, thus could not be evaporated under TGA conditions (Figure 2.3.4). There
was no evidence suggesting that the carbonization of Gal2 remained quantitatively the
same before and after the attachment to nanotubes. Therefore, the TGA results (Figure
2.3.4) could not be used to provide a reasonable estimate of the nanotube content. On the
other hand, the solubility of Gal2-MWNT allowed the classical sugar analysis in aqueous
solution, which is based on spectrophotometry with anthrone as the coloring agent.7
According to the analysis, the sample solution contained 0.12 mg/mL of galactose (or 0.2
mg/mL Gal2). Thus, the Gal2 content in the solid-state Gal2-MWNT sample was 67 %
wt/wt (the remaining 33 % wt/wt being MWNTs).

98

Figure 2.3.1 A visual comparison of the supernatants from centrifuging
the aqueous dispersions of Gal2-MWNT (left) and GalMWNT (right).
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Figure 2.3.2 1H NMR spectra of Gal2-MWNT (top) in comparison with
that of Gal2 (bottom), both in room-temperature D2O.
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Figure 2.3.3 Representative SEM (top left), TEM (dark-field, top right), and
AFM (amplitude: bottom left, and topography: bottom right)
images of the Gal2-MWNT sample. The SEM specimen was from
evaporation of a concentrated Gal2-MWNT solution, while the
AFM specimen was from spraying a more dilute sample solution
onto a heated mica substrate to preserve nanotube dispersion.
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−−−−), and the MWNT sample (-.-.-).
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2.3.4 Summary
In the solubilization of carbon nanotubes via chemical functionalization, the size
of the functional group relative to that of the nanotube should be a critical factor. The
results presented here are rather striking, providing a useful piece of evidence for the
expected effect. The Gal-SWNT is soluble,6 but not Gal-MWNT because MWNTs are
considerably larger than SWNTs. It requires a larger functional group like Gal2 to “drag”
the nanotube into solution. The solubilization is obviously important to the purpose of
these materials. The reported work shows that similar to SWNTs, MWNTs can also be
used to display multiple copies of sugars in physiological solution, which thus makes it
possible to exploit those properties only available to sugar-functionalized MWNTs. In
addition, since Gal-SWNT is known to exhibit significant cell adhesion,6 the galactose
pairs displayed on the nanotube scaffold may prove to be more efficient in the binding
with cells. A comparative biological evaluation of these materials is discussed in later
chapters.
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2.4 Single-Walled Carbon Nanotube as Unique Scaffold
for Multivalent Display of Sugars
2.4.1 Introduction
Multivalent carbohydrate ligands are known to be considerably more potent than
their monovalent counterparts in biological ligand-receptor interactions.1,2 Therefore,
there have been growing recent interests in various multivalent ligands and their
associated configurations for a wide range of applications,3 including the development of
high-affinity inhibitors and drugs.2 Among more extensively studied scaffolds for the
display of multivalent carbohydrate ligands are dendrimers,4 linear and polydispersed
polymers,5 metal nanoparticles,6 polymeric nanospheres,7,8 and so on. For example,
Stoddart and coworkers synthesized highly branched carbohydrate dendrimer containing
3-36 peripheral α-D-mannose copies and evaluated their binding affinity to Con A lectin.9
Disney, et al. reported the use of a carbohydrate-conjugated fluorescent polymer, poly(pphenylene ethynylene), to detect pathogenic Escherichia coli.10 For the binding with E.
coli, Wu and coworkers attached D-mannose moieties to gold nanoparticles to target
selectively the type 1 pili of the ORN178 strain.6a Qu, et al. developed sugar-coated
polystyrene nanobeads for the binding and agglutination of E. coli cells.7
Single-walled carbon nanotubes (SWNTs) have attracted much recent attention
for potential biological applications,11-18 including their functionalization with various
bioactive species such as carbohydrates,12 DNA,13 proteins,14 and peptides.15 The unique
pseudo-one-dimensional structure of SWNT has been exploited to serve as a linear and
semi-flexible nanoscale carrier for displaying multiple copies of biomolecules in specific

interactions with cells. A representative example is due to Elkin, et al. who used the
bovine serum albumin-functionalized SWNTs in conjugation with E. coli-specific
antibody to capture the pathogen in physiological solution.16 In another example, Gu, et
al. solubilized SWNTs via covalent functionalization with the derivatized 2-aminoethylβ-D-galactopyranoside (Scheme 2.4.1) in likely the amidation of nanotube-bound
carboxylic acids.17 These galactose-functionalized nanotubes (Gal-SWNT), each
displaying multiple copies of the sugar, were found to have adhesion to pathogenic E.
coli O157:H7 to result in significant cell agglutination (see chapter 2.2).17 Recently,
Wang, et al. found that monosaccharides (β-D-galactoses or α-D-mannoses)functionalized SWNTs bind to and aggregate effectively Bacillus anthracis (Sterne)
spores in the presence of a divalent cation (such as Ca2+) and that the binding is unique to
the nanotube-displayed carbohydrates.18
In the functionalization of nanotubes with tethered β-D-galactoses and α-Dmannoses, the carboxylic acid moieties on the nanotubes, which are resulted from the
oxidation of the surface defects, have been targeted.19 With limited defect sites on the
nanotube surface, a higher population of multivalent ligands could be attained by using
sugar dendrons (Scheme 2.4.1) in the nanotube functionalization. The resulting larger
number of displayed ligands per nanotube also corresponds to significantly improved
aqueous solubility of the functionalized nanotube samples,20 which not only enhances
biocompatibility but also enables more quantitative characterization for a better
understanding of the structural details on the nanotubes displaying multivalent
carbohydrate ligands. In this chapter, we report the synthesis and characterization of
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dendritic β-D-galactopyranosides and α-D-mannopyranosides for the functionalization of
SWNTs (Scheme 2.4.1). As the functionality varies from mono-, bis-, to tetra-, the
population of the sugar moieties in the functionalized nanotube sample increases, as are
improved solubility and related properties. Results from the biological evaluation of these
sugar-functionalized SWNTs in binding assays with pathogenic E. coli and with Bacillus
subtilis (a nonvirulent simulant for Bacillus anthracis or anthrax) spores are presented
and discussed.

2.4.2 Experimental Section
2.4.2.1 Materials
t-Butyl bromoacetate, N-hydroxy-succinimide, triphenylphosphine, trifluoroacetic
acid (TFA), Palladium (10 wt% on activated carbon), 1-[3-(dimethylamino)propyl]-3ethylcarbodiimide hydrochloride (EDAC), and amberlite IR-120 (plus) ion-exchange
resin were purchased from Sigma-Aldrich. 3, 5-Dihydroxybenzyl alcohol, 18-crown-6,
N,N’-dicyclohexyl-carbodiimide, β-D-galactose-pentaacetate, α-D-mannose, pyridine, and
anthrone were obtained from Acros. N-Bromosuccinimide was supplied by ACOCADO
Research Chemicals, Ltd. Sodium azide were from Alfa Aesar. Ethanol, chloroform,
methylene chloride, THF, DMF, and diethyl ether were from Fisher. Solvent grade THF
was dried and distilled over molecular sieves and then distilled over sodium before use.
Other solvents were either spectrophotometry/HPLC grade or purified via simple
distillation. Deuterated NMR solvents were obtained from Cambridge Isotope
Laboratories.
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n

The sample of SWNT (arc-discharge method) was bought from Carbon Solutions,
Inc. It was purified by using a combination of thermal oxidation and oxidative acid
treatment. In a typical experiment, a nanotube sample (1 g) was thermally oxidized in air
in a furnace at 300 °C for 30 min. After the thermal treatment, the remaining sample was
added to an aqueous HNO3 solution (2.6 M), and the mixture was refluxed for 48 h. Upon
centrifuging at 1380g (Fisher scientific, centric 228 centrifuge) to discard the supernatant,
the remaining solids were washed with deionized water until neutral pH and then dried
under vacuum.

2.4.2.2 Measurements
NMR measurements were carried on a JEOL Eclipse +500 NMR spectrometer
and a Bruker Advance 500 spectrometer that is equipped with a high-resolution magicangle-spinning (HR-MAS) probe designed specifically for gel-phase NMR. The residual
proton and carbon resonance of the deuterium solvents were used as internal standards.
MALDI-TOF MS was performed on a Bruker AutoFlex system, with 2, 5dihydroxybenzoic acid as the sample matrix. Optical absorption spectra were recorded on
a Shimadzu UV3600 UV-VIS-NIR spectrophotometer. Thermo gravimetric analysis
(TGA) was carried out on a Mettler-Toledo TGA/SDTA851e system. Raman spectra
were obtained on a JoBin Yvon T64000 spectrometer equipped with a Melles-Griot
35mW He: Ne laser source for 632.8 nm excitation, a triple monochromator, a research
grade Olympus BX-41 microscopy and a liquid nitrogen-cooled symphony detector.
Scanning electron microscopy (SEM) images were obtained on a Hitachi S4700 field-
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emission SEM system. Atomic force microscopy (AFM) analysis was conducted on a
Molecular Imaging PicoPlus system equipped with a multipurpose scanner. The height
profile analyses were assisted by using the SPIP software distributed by Image
Metrology.
The spectrophotometric method with the use of anthrone reagent was used to
determine sugar contents.21 As described in chapter 2.2, a solution of sugarfunctionalized SWNTs (50 µL) was mixed with deionized water (50 µL), HCl (37%, 1
mL), formic acid (0.1 mL) and anthrone reagent (8 mL, 0.2 mg/mL in 80% H2SO4). The
solution mixture was kept in a boiling water bath for 12 min, and then rapidly cooled in
an ice bath for 30 min. The UV/vis absorption of the mixture was measured and
corrected. Separately, the standard sugar (β-D-galactose or α-D-mannose) solutions of
known concentration (1.0 mg/mL) were prepared. Various aliquots of the standard
solutions (0, 25, 50, 75, and 100 µL) were tested in terms of the same procedure above to
establish standard curves, from which the sugar content in the functionalized nanotube
sample was obtained.

2.4.2.3 Synthesis of Sugar Dendrons
The sugar monomers (Gal- and Man-) were prepared using procedures already
available in the literature (see chapter 2.2).22 For the sugar dendrons, the compound 1
(Scheme 2.4.2) was synthesized from t-butyl bromoacetate (through iodide substitution)
and 3, 5-dihydroxybenzyl alcohol also according to procedures already reported in the
literature.23
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1. At first, a mixture of sodium iodide (10 g, 75 mmol) and tert-butyl bromoacetate (9.75 g, 50 mmol) in acetone (50 mL) was refluxed for 12 hrs. The reaction
mixture was allowed to cool and solvent was evaporated to dryness. The residue was then
partitioned between water and chloroform. The organic layer was collected and dried
with anhydrous MgSO4, solvent was evaporated to dryness to afford tert-butyl
iodoacetate as a brownish liquid (12 g, quantitative): 1H NMR (300 MHz, CDCl3) δ 3.62
(s, 2H), 1.48 (s, 9H); 13C NMR (75.4 MHz, CDCl3) δ 167.8, 82.3, 27.6, -2.6 ppm.
At r.t., 3, 5-dihydroxybenzyl alcohol (2.8 g, 20 mmol) was dissolved in dry
acetone (100 mL). To this solution were added, K2CO3 (6.6 g, 48 mmol), 18-crown-6
(1.057 g, 4 mmol), and tert-butyl iodoacetate (10.65 g, 44 mmol). The reaction mixture
was refluxed for 36 hrs. After been cooled to r.t., solvent was evaporated and the residue
was partitioned between water and ethyl acetate. The water potion was extracted with
ethyl acetate for 3 times. The combined organic layer was dried with anhydrous MgSO4
and concentrated. The crude product was purified by chromatography with hexane/ethyl
acetate (2:1.5) as the eluent to yield a colorless oil (7.1g, 96%): 1H NMR (500 MHz,
CDCl3) δ 6.56 (d, J = 2 Hz, 2H), 6.43 (t, J = 2.25 Hz, 1H), 4.64 (s, 2H), 4.51 (s, 4H), 1.51
(s, 18H); 13C NMR (125.7 MHz, CDCl3) δ 167.8, 159.3, 143.6, 105.9, 101.2, 82.4, 65.8,
65.2, 28.1 ppm.
For the last step, at r.t., triphenyl phosphine (2.911 g, 11.1 mmol) and product of
step 2 were stirred in dry THF (20 mL). After 7 mins, N-bromosuccinimide (1.976 g,
11.1 mmol) was added and stirred for another 5 mins. Water was then added to quench
the reaction. Crude product was extracted by chloroform for three times, organic fraction
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Scheme 2.4.2 Synthesis of serial sugar dendrons.
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was dried (MgSO4), condensed, and purified by silica gel chromatography with eluent of
hexane/ethyl acetate (4:1). After dried in vacuum oven, 1 obtained as a whitish solid
(3.018 g, 95%).1H NMR (500 MHz, CDCl3): δ 6.57 (d, J = 2.5 Hz, 2H), 6.44 (t, J = 2.25
Hz, 1H), 4.51 (s, 4H), 4.41 (s, 2H), 1.51 (s, 18H);

13

C NMR (125.7 MHz, CDCl3): δ

167.63, 159.17, 139.84, 108.38, 102.15, 82.52, 65.80, 33.16, 28.06 ppm. MALDI-TOF
MS (M+Na+): (theoretically 453.09).
2. A solution of 1 (1.51 g, 3.5 mmol) in dry CH2Cl2 (10 mL) was prepared, and at
0 ºC trifluoroacetic acid (4 mL) was added. The mixture was warmed back to room
temperature and stirred for 12 h. The precipitate was collected via filtration and then
dried in a vacuum oven to yield the hydrolyzed product 1’ as a white solid (1.1 g,
quantitative): 1H NMR (500 MHz, MeOH-d4) δ 6.66 (d, J = 2 Hz, 2H), 6.51 (t, J = 2.25
Hz, 1H), 4.67 (s, 4H), 4.51 (s, 2H);

13

C NMR (125.7 MHz, MeOH-d4) δ 171.0, 159.2,

140.5, 108.1, 101.6, 64.6, 32.3 ppm.
At 0 ºC, a solution of N, N’-dicyclohexyl-carbodimide (990.3 mg, 4.8 mmol) in
dry THF (20 mL) was added dropwise over 30 min to another THF solution (30 mL) of
1’ (638.7 mg, 2 mmol) and N-hydroxy-succinimide (552.4 mg, 4.8 mmol). The mixture
was warmed back to room temperature and stirred in the dark for 12 h. The precipitated
urea was removed via filtration, and the remaining solution was slowly dropped into a
CH2Cl2 solution (20 mL) of freshly prepared Gal’-NH2 (2.0 g, 4.8 mmol).20 After stirring
for 12 h and then solvent removal, the reaction mixture was separated on a silica gel
column (first hexane-ethyl acetate at 10/90 v/v, and then methanol-ethyl acetate at 5/95
v/v) to yield 2(Gal’) as a white solid (2.13 g, 99%): 1H NMR (500 MHz, CDCl3) δ 6.96
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(t, J = 5.75 Hz, 2H, NH), 6.71 (d, J = 2 Hz, 2H), 6.64 (t, J = 2 Hz, 1H), 5.41 (dd, J = 2
Hz, 2H), 5.23 (dd, J = 8 Hz, 2H), 5.03 (dd, J = 3.5 Hz, 2H), 4.52 (s, 4H), 4.51(d, J = 3
Hz, 2H), 4.45 (s, 2H), 4.19-4.14 (m, 4H), 4.0-3.92 (m, 4H), 3.74-3.67 (m, 4H), 3.55-3.48
(m, 2H), 2.18 (s, 6H), 2.07 (s, 6H), 2.04 (s, 6H), 2.02 (s, 6H);

13

C NMR (125.7 MHz,

CDCl3) δ 170.4, 170.2, 170.1, 169.5, 167.7, 158.6, 140.8, 109.1, 102.4, 101.3, 70.9, 70.7,
68.8, 68.5, 67.5, 67.0, 61.3, 38.8, 32.7, 20.7, 20.7(2C), 20.6 ppm. MALDI-TOF MS
(M+Na+): 1089.37 (theoretically 1087.24).
The same procedure was applied to the synthesis of 2(Man’) (2.13 g, 99%): 1H
NMR (500 MHz, CDCl3) δ 7.08 (t, J = 5.25 Hz, 2H, NH), 7.01 (d, J = 1.85 Hz, 2H), 6.59
(t, J = 2.25 Hz, 1H), 5.37 (dd, J = 3.2 Hz, 2H), 5.31-5.27 (m, 4H), 4.87 (d, J = 1.4 Hz,
2H), 4.55 (s, 4H), 4.46 (s, 2H), 4.28-4.25 (dd, J = 5.5 Hz, 2H), 4.15-4.12 (m, 2H), 4.003.97 (m, 2H), 3.88-3.85 (m, 2H), 3.71-3.64 (m, 2H), 3.63-3.57 (m, 4H), 2.18 (s, 6H), 2.12
(s, 6H), 2.05 (s, 6H), 2.00 (s, 6H); 13C NMR (125.7 MHz, CDCl3) δ 170.6, 170.1, 170.0,
169.7, 167.8, 158.4, 140.7, 109.0, 102.1, 97.6, 69.4, 69.0, 68.9, 67.3, 66.8, 66.0, 62.5,
38.4, 32.7, 20.9, 20.7 (2C), 20.6 ppm. MALDI-TOF MS (M+Na+): 1088.54 (theoretically
1087.24).
Gal2-N3 and Man2-N3. The azide substitution and deprotection reactions of 2
were similar to those reported previously,20 yielding quantitatively Gal2-N3 [1H NMR
(500 MHz, MeOH-d4) δ 6.71-6.68 (m, 3H), 4.56 (s, 4H), 4.35 (s, 2H), 4.25 (d, J = 12.5
Hz, 2H), 3.01-3.94 (m, 2H), 3.85-3.83 (dd, 2H), 3.77-3.67 (m, 6H), 3.62-3.43 (m, 10H);
13

C NMR (125.7 MHz, MeOH-d4) δ 169.6, 159.2, 138.6, 107.7, 103.9, 101.7, 75.4, 73.5,

71.1, 68.9, 68.1, 67.0, 61.1, 53.9, 39.0 ppm. MALDI-TOF MS (M+Na+): 714.83
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(theoretically 714.24)] and Man2-N3 [1H NMR (500 MHz, MeOH-d4) δ 6.66-6.65 (m,
3H), 4.74 (d, J = 1.4 Hz, 2H), 4.54 (s, 4H), 4.33 (s, 2H), 3.81-3.74 (m, 6H), 3.69-3.64 (m,
4H), 3.61-3.51 (m, 8H), 3.48-3.43 (m, 2H);

13

C NMR (125.7 MHz, MeOH-d4) δ 169.7,

159.2, 138.7, 107.7, 101.6, 101.3, 73.5, 71.2, 70.7, 67.3, 67.0, 65.7, 61.6, 54.0, 38.6 ppm.
MALDI-TOF MS (M+): 690.77 (theoretically 691.25)]. These compounds were relatively
stable, and they were freshly reduced to Gal2-NH2 and Man2-NH2 before the nanotube
functionalization reaction.
3. There were two steps (Scheme 2.4.2), with the first being the conversion of the
bromide in 1 to iodide (1’’). 1 (3.018 g, 7 mmol) and sodium iodide (10 g, 67 mmol)
were refluxed in acetone (50 mL) for 12 h. The reaction mixture was allowed to cool, and
then the solvent was evaporated completely. The residue was partitioned between water
and chloroform. The organic layer was collected and dried with anhydrous MgSO4,
followed by the removal of solvent to yield 1’’ (3.56 g, quantitative): 1H NMR (500
MHz, CDCl3) δ 6.53 (d, J = 2.3 Hz, 2H), 6.37 (t, J = 2.05 Hz, 1H), 4.48 (s, 4H), 4.35 (s,
2H), 1.50 (s, 18H); 13C NMR (125.7 MHz, CDCl3) δ 167.7, 159.2, 141.4, 108.2, 101.7,
82.6, 65.8, 28.2, 5.1 ppm.
In the second step, a solution of 3,5-dihydroxybenzyl alcohol (490 mg, 3.5
mmol), K2CO3 (2 g, 14 mmol), and 18-crown-6 (172 mg, 0.7 mmol) in acetone (30 mL)
was prepared, and to the solution was added 1’’ (3.56 g, 7 mmol). After refluxing for 36
h and then solvent removal, the reaction mixture was partitioned between water and ethyl
acetate. The aqueous potion was repeatedly extracted with ethyl acetate. The combined
ethyl acetate solution was dried with anhydrous MgSO4, followed by silica gel column
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(hexane-ethyl acetate at 1:1.5) separation to obtain 3 (2.55 g, 87% yield): 1H NMR (500
MHz, CDCl3) δ 6.56 (d, J = 2.3 Hz, 4H), 6.55 (d, J = 1.85 Hz, 2H), 6.45 (t, J = 2.25 Hz,
1H), 6.40 (t, J = 2.25 Hz, 2H), 4.93 (s, 4H), 4.60 (s, 2H), 4.47 (s, 8H), 1.46 (s, 36H); 13C
NMR (125.7 MHz, CDCl3) δ 167.9, 159.95, 159.2, 143.9, 139.6, 106.5, 105.7, 101.4,
101.2, 82.5, 69.7, 65.8, 65.0, 28.1 ppm. MALDI-TOF MS (M+Na+): 863.29 (theoretically
863.38).
4. The first step was to convert the benzyl alcohol in 3 to benzyl bromide (3’). 3
(3.075 g, 3.675 mmol) was added to a THF (20 mL) solution of triphenyl phosphine (1.44
g, 5.5 mmol). After stirring for 7 min, N-bromosuccinimide (979 mg, 5.5 mmol) was
added, and the mixture was stirred for 5 min more. Water was added to quench the
reaction. The crude product was extracted with chloroform three times. The organic
fraction was dried with anhydrous MgSO4, condensed, and purified by silica gel
chromatography with hexane-ethyl acetate (3/1 v/v) as eluent. 3’ was obtained as a white
solid (2.76 g, 83% yield): 1H NMR (500 MHz, CDCl3) δ 6.59 (d, J = 2.5 Hz, 2H), 6.58
(d, J = 2 Hz, 4H), 6.47 (t, J = 2.25 Hz, 1H), 6.44 (t, J = 2.25 Hz, 2H), 4.93 (s, 4H), 4.49
(s, 8H), 4.39 (s, 2H), 1.48 (s, 36H); 13C NMR (125.7 MHz, CDCl3) δ 167.7, 159.9, 159.3,
139.8, 139.3, 108.3, 106.5, 102.2, 101.5, 82.4, 69.8, 65.8, 33.4, 28.0 ppm. MALDI-TOF
MS (M+Na+): 927.31 (theoretically 925.30).
A solution of 3’ (2.4 g, 2.6 mmol) in CH2Cl2 (20 mL) was prepared, and at 0 ºC
trifluoroacetic acid (4 mL) was added. The mixture was warmed back to room
temperature and stirred for 12 h. The precipitate was collected by vacuum filtration, and
then dried in a vacuum oven to yield 4 as a white solid (1.78 g, quantitative): 1H NMR
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(500 MHz, MeOH-d4) δ 6.68 (d, J = 2 Hz, 2H), 6.67 (t, J = 2.5 Hz, 4H), 6.56 (t, J = 2 Hz,
1H), 6.51 (t, J = 2.25 Hz, 2H), 5.02 (s, 4H), 4.66 (s, 8H), 4.49 (s, 2H); 13C NMR (125.7
MHz, MeOH-d4) δ 171.1, 160.0, 159.3, 140.4, 139.9, 108.3, 106.2, 101.8, 101.0, 69.4,
64.7, 32.6 ppm. MALDI-TOF MS (M+Na+): 703.19 (theoretically 701.05).
5(Gal’) and 5(Man’). Two THF solutions (10 mL each) were prepared, with one
for 4 (340 mg, 0.5 mmol) and N-hydroxy-succinimide (345 mg, 3 mmol) and the other
for N, N’-dicyclohexyl-carbodiimide (619 mg, 3 mmol). At 0 ºC, the second solution was
added to the first dropwise over 30 min. The reaction mixture was gradually warmed to
room temperature and stirred in dark for 12 h. The insoluble urea was removed by
filtration, and the filtrate was slowly dropped into a CH2Cl2 solution (20 mL) of freshly
prepared Gal’-NH2 (1.0 g, 2.4 mmol).20 After stirring for 12 h and then solvent removal,
the reaction mixture was separated on silica gel column (first hexane-ethyl acetate at 1:9,
and then methanol-ethyl acetate at 1:9) to afford 5(Gal’) as white solids (728 mg, 67%
yield): 1H NMR (500 MHz, CDCl3) δ 6.94 (t, J = 5.95 Hz, 4H, NH), 6.66 (d, J = 1.85 Hz,
4H), 6.59 (d, 2H), 6.58 (t, 2H), 6.48 (t, 1H), 5.31 (d, J = 3.2 Hz, 4H), 5.13 (dd, J = 7.8
Hz, 4H), 4.98-4.92 (m, 8H), 4.44 (s, 8H), 4.42 (d, J = 8.25 Hz, 4H), 4.36(s, 2H), 4.104.02 (m, 8H), 3.90-3.82 (m, 8H), 3.68-3.56 (m, 8H), 3.46-3.40 (m, 4H), 2.07 (s, 12H),
1.97 (s, 12H), 1.94 (s, 12H), 1.92 (s, 12H);

13

C NMR (125.7 MHz, CDCl3) δ 170.4,

170.3, 170.2, 169.5, 167.9, 158.8, 158.7, 140.1, 140.0, 108.3, 107.0, 102.2, 102.1, 101.3,
70.8, 70.8, 69.6, 68.8, 68.6, 67.5, 67.0, 61.3, 38.8, 33.4, 20.8, 20.7 (2C), 20.6 ppm.
MALDI-TOF MS (M+Na+): 2195.56 (theoretically 2193.60).
The same procedure was applied to the synthesis of 5(Man’) (1.37 g, 63% yield):

118

1

H NMR (500 MHz, CDCl3) δ 7.06 (t, J = 5.95 Hz, 4H, NH), 6.68 (d, J = 1.85 Hz, 4H),

6.60 (d, J = 1.85 Hz, 2H), 6.56 (t, 2H), 6.50 (t, 1H), 5.32-5.29 (m, 4H), 5.24-5.18 (m,
8H), 4.97 (s, 4H), 4.81 (s, 4H), 4.50 (s, 8H), 4.38(s, 2H), 4.23-4.19 (dd, J = 5.75 Hz, 4H),
4.09-4.03 (m, 4H), 3.95-3.92 (m, 4H), 3.82-3.78 (m, 4H), 3.66-3.49 (m, 12H), 2.11 (s,
12H), 2.06 (s, 12H), 1.96 (s, 12H), 1.94 (s, 12H);

13

C NMR (125.7 MHz, CDCl3): δ

170.7, 170.2 (2C), 169.8, 168.0, 159.9, 158.6, 140.1, 140.0, 108.3, 107.1, 102.2, 102.0,
97.7, 69.6, 69.4, 69.0, 68.9, 67.3, 66.9, 66.1, 62.6, 38.5, 33.5, 20.9, 20.8, 20.8, 20.7 ppm.
MALDI-TOF MS (M+Na+): 2194.28 (theoretically 2193.60).
Gal4-N3 and Man4-N3. The first step was to convert the bromide in 5 to azide
(Gal’4-N3 and Man’4-N3). For Gal’4-N3, a solution of 5(Gal’) (728 mg, 0.34 mmol) in
acetone (20 mL) was prepared, and to the solution was added sodium azide (0.22 g, 3.4
mmol) and 18-crown-6 (54 mg, 0.2 mmol). The mixture was refluxed for 12 h, and then
cooled to room temperature. The solvent was evaporated, and the residue was partitioned
between water and ethyl acetate. The aqueous layer was extracted with ethyl acetate
twice. All of the ethyl acetate fractions were combined and dried with anhydrous MgSO4.
The solvent was evaporated, and the residue was dried in a vacuum oven to yield Gal’4N3 as a white solid (715 mg, quantitative): 1H NMR (500 MHz, CDCl3) δ 6.98 (t, J = 5.5
Hz, 4H, NH), 6.65 (s, 4H), 6.59 (s, 2H), 6.52 (s, 1H), 6.50 (s, 2H), 5.32 (d, J = 3.25 Hz,
4H), 5.13 (dd, J = 7.55 Hz, 4H), 4.96 (s, 4H), 4.93 (d, J = 3.65 Hz, 4H), 4.44 (s, 8H), 4.42
(d, 4H), 4.22 (s, 2H), 4.07 (d, J = 6.85 Hz, 8H), 3.90-3.83 (m, 8H), 3.68-3.56 (m, 8H),
3.45-3.40 (m, 4H), 2.07 (s, 12H), 1.96 (s, 12H), 1.94 (s, 12H), 1.91 (s, 12H); 13C NMR
(125.7 MHz, CDCl3) δ 170.5, 170.3, 170.2, 169.6, 168.0, 160.0, 158.7, 140.0, 138.0,
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107.3, 107.0, 102.1, 101.9, 101.3, 70.8, 70.8, 69.6, 68.8, 68.5, 67.4, 67.0, 61.3, 54.7, 38.8,
20.8, 20.7 (2C), 20.6 ppm. MALDI-TOF MS (M+Na+): 2157.43 (theoretically 2156.69).
The same procedure was applied to the synthesis of Man’4-N3 (1.02 g, quantitative): 1H
NMR (500 MHz, CDCl3) δ 7.01 (t, J = 5.5 Hz, 4H, NH), 6.64 (d, J = 2 Hz, 4H), 6.53 (t, J
= 2 Hz, 2H), 6.51 (t, J = 2 Hz, 1H), 6.49 (d, J = 2 Hz, 2H), 5.29-5.26 (m, 4H), 5.22-5.17
(m, 8H), 4.95 (s, 4H), 4.78 (d, J = 1 Hz, 4H), 4.46 (s, 8H), 4.20-4.17 (m, 6H), 4.03(dd, J
= 2.75 Hz, 4H), 3.93-3.89 (m, 4H), 3.79-3.74 (m, 4H), 3.63-3.57 (m, 4H), 3.57-3.46 (m,
8H), 2.08 (s, 12H), 2.02 (s, 12H), 1.93 (s, 12H), 1.91 (s, 12H);

13

C NMR (125.7 MHz,

CDCl3): δ 170.7, 170.2 (2C), 169.8, 168.0, 160.1, 158.5, 140.0, 138.0, 107.4, 107.0,
102.0, 101.9, 97.7, 69.6, 69.4, 69.0, 68.9, 67.3, 66.9, 66.1, 62.5, 54.8, 38.5, 21.0, 20.8,
20.7, 20.6 ppm. MALDI-TOF MS (M+): 2134.08 (theoretically 2133.69).
For Gal4-N3, a solution of Gal’4-N3 (715 mg, 0.334 mmol) in CH3ONa/CH3OH
(0.05 M, 30 mL) was prepared. After the solution was stirred for 12 h, Amberlite IR120(plux) ion-exchange resin was added to adjust the pH to 7.0. The resin was removed
via filtration, and the solution was dried with anhydrous MgSO4, followed by solvent
evaporation to yield Gal4-N3 as a white solid (490 mg, quantitative): 1H NMR (500 MHz,
D2O) δ 6.47 (s, 4H), 6.43 (s, 2H), 6.36 (s, 2H), 6.26 (s, 1H), 4.63 (s, 4H), 4.32 (d, J = 7.5
Hz, 4H), 4.26 (s, 8H), 4.13 (s, 2H), 3.97-3.94 (m, 4H), 3.88 (d, 4H), 3.77-3.70 (m, 12H),
3.62-3.57 (m, 8H), 3.54-3.50 (m, 8H), 3.47-3.41 (m, 4H); 13C NMR (125.7 MHz, D2O) δ
170.5, 159.2, 158.3, 139.5, 138.4, 107.2, 106.9, 103.2, 101.4 (2C), 75.2, 72.8, 70.8, 69.2,
68.6, 68.3, 66.4, 61.0, 54.0, 39.1 ppm. MALDI-TOF MS (M+Na+): 1484.50 (theoretically
1484.52). The same procedure was applied to the quantitative conversion of Man’4-N3 to
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Man4-N3: 1H NMR (500 MHz, D2O) δ 6.41 (s, 4H), 6.37 (s, 2H), 6.34 (s, 2H), 6.23 (s,
1H), 4.75 (s, 4H), 4.61 (s, 4H), 4.24 (s, 8H), 4.05 (s, 2H), 3.81 (m, 4H), 3.76 (d, 4H),
3.70-3.65 (m, 12H), 3.62-3.57 (m, 4H), 3.54-3.50 (m, 8H), 3.47-3.42 (m, 4H), 3.36-3.32
(m, 4H); 13C NMR (125.7 MHz, D2O) δ 169.4, 159.2, 158.3, 139.6, 138.4, 107.4, 106.8,
101.6, 101.3, 99.7, 72.9, 70.6, 70.1, 69.2, 66.7, 66.5, 65.7, 60.9, 54.0, 38.6 ppm. MALDITOF MS (M+): 1461.38 (theoretically 1461.53).

2.4.2.4 Nanotube Functionalization
Before the functionalization reaction, Gal4-N3 and Man4-N3 were reduced to Gal4NH2 and Man4-NH2 by the classical palladium-catalyzed hydrogenation. At 0 ºC, to a
solution of Gal4-N3 or Man4-N3 (800 mg, 0.55 mmol) in methanol-H2O (10 mL) was
added Pd/C (10 wt% palladium on activated carbon, 70 mg). The reaction mixture was
gradually warmed to room temperature and stirred with the purging of hydrogen gas for 4
h. The Pd/C was removed by filtration, and the filtrate was evaporated to obtain Gal4NH2 or Man4-NH2.
In the functionalization of SWNTs with Gal4-NH2, a purified nanotube sample (20
mg) was mixed with 1-ethyl-3-(3-dimethylaminoprop-yl) carbodiimide (EDAC, 112 mg,
60 mmol) in aqueous KH2PO4 buffer (45 mL, pH = 7.4). Upon sonication for 2 h, the
freshly prepared Gal4-NH2 (0.55 mmol) was added. After sonication for another 36 h, the
reaction mixture was loaded into a membrane tubing (cutoff molecular weight ~ 12,000)
for dialysis against deionized water for 3 days. The suspension from the dialysis was
centrifuged at 3,000g for 30 min to obtain a dark but optically transparent solution of
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Gal4-SWNT: 1H NMR (500 MHz, D2O) δ 6.72 (broad), 6.61 (s, broad), 6.55 (broad),
6.50-6.40 (broad), 4.50 (s, broad), 4.35 (d, broad), 3.98 (s, broad), 3.93 (s, broad), 3.76 (s,
broad), 3.64 (broad), 3.54 (broad), 3.50 (broad);

13

C NMR (125.7 MHz, D2O) δ 171.0,

158.5, 106.6, 103.2, 75.1, 72.7, 70.8, 69.6, 68.6, 68.4, 66.6, 60.9, 39.1 ppm. Similarly for
Man4-SWNT: 1H NMR (500 MHz, D2O) δ 6.5-6.2 (broad), 4.35-4.10 (broad), 3.91 (s,
broad), 3.85 (d, broad), 3.77 (d, broad), 3.67 (t, broad), 3.55-3.40 (broad), 3.43 (broad);
13

C NMR (125.7 MHz, D2O): δ 170.4, 159.2, 158.3, 139.5, 107.0, 101.2, 99.7, 72.9, 70.6,

70.1, 69.2, 66.7, 66.4, 65.7, 60.9, 38.6 ppm.
Gal2-N3 and Man2-N3 were similarly reduced and used to functionalize SWNTs
resulting Gal2-SWNT: 1H NMR (500 MHz, D2O) δ 6.82 (s), 6.70 (s), 6.6-6.4 (broad),
4.71 (s), 4.40 (d, broad), 4.03 (m, broad), 3.95 (s, broad), 3.90-3.70 (broad), 3.70-3.60
(broad), 3.60-3.50 (broad); 13C NMR (125.7 MHz, D2O) δ 103.1, 75.2, 72.7, 70.8, 68.6,
68.4, 66.9, 61.0, 39.1 ppm. Man2-SWNT: 1H NMR (500 MHz, D2O) δ 6.82 (s), 6.70 (s),
6.64 (s), 6.58 (s), 6.47 (s), 4.61 (s, broad), 4.53 (s, broad), 4.38 (d, broad), 3.86 (d, broad),
3.80-3.70 (m, broad), 3.70-3.60 (m, broad), 3.60-3.50 (m, broad); 13C NMR (125.7 MHz,
D2O): δ 171.1, 158.5, 99.6, 72.8, 70.5, 70.0, 66.7 (2C), 65.8, 60.9, 38.6 ppm.

2.4.2.5 Assay for E. coli
The green fluorescent protein (GFP)-expressing E. coli O157:H7/pWM1007
was transformed through electroporation.24 The frozen E. coli samples were
recovered and cultured on tryptic soy agar (TSA) plates supplemented with
kanamycin (50 µg/mL). After overnight growth at 37 °C, the bacteria were harvested
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and washed with phosphate buffer solution (PBS) via the centrifuging-suspending
cycle three times. Finally the E. coli cells were suspended in PBS to an optical
density of 0.6 at 600 nm (~108 cells/mL).
In cell adhesion and precipitation experiment, a suspension (25 µL) of E. coli
O157:H7/pWM1007 cells was two-fold serially diluted and incubated with a solution (10
µL) of either Gal-SWNT (0.14 mg/mL) or Gal2-SWNT (0.13 mg/mL) for 3 h at room
temperature with gentle inversions of the tubes at 15 min intervals. The precipitates at the
tube bottom were collected and wet-mounted onto a glass slide for microscopy analyses.
For the colony-forming units (CFU) reduction assay, the same procedure
described above was used, and at the end of incubation the mixture was centrifuged with
a low force (300g) for 30 seconds. The supernatant was collected and ten-fold serially
diluted. At each dilution 100 µL was plated out (in triplicate) onto TSA agar plates by
using spread plate technique. The plates were incubated overnight at 37 °C. CFU was
counted, and the percentage of CFU reduction was calculated and compared to that of the
control without the sugar-functionalized SWNTs.

2.4.2.6 Assay for B. subtilis Spores
B. subtilis spores (strain ATCC33234) were supplied by American Type Culture
Collection (Manassas, VA), and the spore suspension was prepared by following
established procedures. In a typical binding experiment, an aqueous suspension of B.
subtilis spores (40 µL, 2.6 × 108 CFU/mL) was mixed with a solution of mannosefunctionalized SWNTs (40 µL, 0.2 mg/mL mannose equivalent concentration) or with
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distilled water (40 µL) as control, followed by the addition of aqueous CaCl2 (20 µL, 100
mM). The mixtures (sample and control) were rotated for 12 h. A small aliquot (10 µL)
of the sample (or control) was dropped onto a glass slide (covered with cover glass slide)
for optical microscopy analyses.

2.4.3 Results and Discussion
The sugar dendrons Gal2-NH2, Man2-NH2, Gal4-NH2, and Man4-NH2 were
prepared by using tri-substituted benzenes (3,5-dihydroxybenzyl alcohol and 1) as
building blocks in classical etherification and carbodiimide-activated amidation reactions
(Scheme 2.4.2), with generally high product yields. The synthetic strategy was such that
the dendritic framework was constructed first before being coupled with the aminetethered monosaccharide. A significant advantage of the strategy is that sugar molecules
are involved only in the end steps, thus difficulties associated with the sugar deprotection and stereo hindrance are avoided.
The same carbodiimide-activated amidation was used in the functionalization of
SWNTs with the dendrons, with the tethered amino groups coupling with the surface
defects-derived carboxylic acids on the nanotubes.19 The functionalization reaction is
heterogeneous in nature, so that typically an excess amount of the functionalization agent
is used. For the functionalization with 2’-aminoethyl-α-D-mannopyranoside (Man-), the
molar ratio of Man- to the nanotube-bound carboxylic acids (estimated at 5% mole
fraction of the nanotube carbons based on titration results) was varied. The results in
Table 2.4.1 show that the amount of SWNTs solubilized in the functionalization reaches
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Table 2.4.1. Results on Man-, Man2-, and Man4- in functionalization/solubilization of
SWNTs.

Starting SWNTs Solubilized (%)

Molar ratio of
sugar-NH2 to
nanotube-COOH

Man-

1:1

7.5

2:1

13

4:1

20

5:1

24

6:1

23

20:1

24

100:1

22
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Man2-

Man4-

35

50

a plateau at the Man-to-acid molar ratio of 5 or so. Thus, at the molar ratio of 100, the
amount of solubilized nanotubes should represent the limit for the functionalization agent
under the otherwise defined experimental parameters and conditions. As shown in Table
2.4.1, the percentage of the starting purified SWNTs solubilized in the functionalization
reaction increases from about 25% for Man- to 35% for Man2- and to 50% for Man4-.The
higher-order sugar dendrons are obviously more effective in the functionalization and
solubilization of SWNTs.
The sugar dendron-functionalized carbon nanotube samples, Gal2-SWNT, Man2SWNT, Gal4-SWNT, and Man4-SWNT, are all readily soluble in water, allowing their
being investigated with solution-phase techniques. The first was the characterization of
the samples by NMR, both in solution and in the gel phase.25 For example, the 1H NMR
spectra of Gal2-SWNT and Gal2-N3 in solutions are compared in Figure 2.4.1a. The
signals of the nanotube sample are obviously significantly broader than those of the
corresponding free dendron, which may be attributed to the high molecular weight and
low mobility of carbon nanotubes.26 For the gel-phase NMR measurement of the same
Gal2-SWNT sample in a high resolution-magic angle spinning (HR-MAS) probe
specifically for the gel-phase, the 1H spectrum is better resolved, with the signal patterns
in the sugar region comparable with those of the free dendron (Figure 2.4.1a). The
aromatic proton signals for Gal2-SWNT are slightly shifted downfield, 6.82 ppm and 6.70
ppm for the nanotube-bound dendron from 6.72 ppm and 6.66 ppm for the free dendron,
respectively, which might be due to the formation of amide linkages affecting the
aromatic ring in the close vicinity. The same effects could be responsible for the absence
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of the benzyl proton signal in the spectrum of Gal2-SWNT because the proton is right
next to the nanotube. This proton has a chemical shift of 4.36 ppm in the spectrum of
Gal2-N3. It is known in the literature that the effect of large aromatic ring currents in
carbon nanotubes on the local magnetic environment of protons in close proximity causes
their resonance to either shift into the region where it is difficult to be identified or to
become too broad to be detected.25-27
Similar 1H NMR results, including effects on the signal broadening and shifting,
were found for other dendron-functionalized SWNTs. Shown in Figure 2.4.2a is a similar
comparison between the 1H NMR spectra of Gal4-SWNT and Gal4-N3 in solutions, and
the comparison between Man4-SWNT and Man4-N3 is largely the same.
13

C NMR spectra of the dendron-functionalized SWNTs , especially Gal4-SWNT and

Man4-SWNT, were readily obtained in solution, unlike those of Gal-SWNT and ManSWNT whose relatively poor solubility (thus low solution concentrations) made their 13C
NMR measurement rather difficult.17 For the comparisons between Gal2-SWNT and
Gal2-N3 (Figure 2.4.1b) and between Gal4-SWNT and Gal4-N3 (Figure 2.4.2b), there are
signal broadening effects from free dendrons to those attached to SWNTs, though
relatively less so from Gal4-N3 to Gal4-SWNT as one would expect. There are Gal carbon
resonances in both Gal2-SWNT (Figure 2.4.1b) and Gal4-SWNT (Figure 2.4.2b) spectra,
and the latter also exhibits some of the tether carbon signals due to the higher solution
concentration and perhaps also to these carbons being farther away from the nanotubes
(less affected by their large ring currents26-27).
The optical absorption spectra of the functionalized SWNTs were measured both
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Figure 2.4.1 Comparisons for (a) the 1H NMR spectra of Gal2-SWNT (top: solution
phase; middle: gel phase) and Gal2-N3 (bottom); and (b) the 13C NMR
spectra of Gal2-SWNT (top, with inset) and Gal2-N3 (bottom). (Peak with
star mark is from solvent MeOH)
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Figure 2.4.3 Optical absorption spectra of (a)Gal2-SWNT; (b) Gal4-SWNT; (c)
Man2-SWNT; and (d) Man4-SWNT in D2O solution (solid line)
and in the solid-state on glass substrate (dashed line).
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Figure 2.4.4 Raman spectra (633 nm excitation) of the functionalized SWNTs and the
starting purified nanotube sample are compared.
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in solution (only down to 1,500 nm because of the overwhelming interference from D2O
beyond that) and in the solid state (samples deposited on the surface of glass slides). The
S11 (~1,880 nm) and S22 (~1,050 nm) bands due to van Hove singularity transitions in
semiconducting SWNTs28 and the weak M11 transition (~740 nm) in metallic SWNTs are
all present in the spectra of dendron-functionalized nanotube samples (Figure 2.4.3),
suggesting the electronic properties of the nanotubes are largely preserved in the
functionalization targeting defects-derived carboxylic acid moieties on the nanotube
surface, as also observed in many other such functionalization schemes.17,25-26 The
solution spectra of Gal4-SWNT and Man4-SWNT are somewhat better resolved than their
solid-state counterparts (Figure 2.4.3). For Gal2-SWNT and Man2-SWNT, the generally
weaker absorption bands in the solution spectra are probably a simple result of their
lower solubility (thus lower solution concentrations).
The sugar dendron-functionalized SWNTs were characterized by Raman with 633
nm excitation. Interestingly, unlike in other well-functionalized nanotube samples,26,29 no
substantial luminescence interference was observed. Thus, resonance Raman spectra
could be measured for all of the dendron-SWNT samples without their being thermally or
chemically defunctionalized first. As compared in Figure 2.4.4, the Raman spectra of the
different dendron-SWNT samples are largely similar among themselves and also similar
to that of the starting purified nanotube sample, exhibiting the typical radial breathing
mode peaks around 140 and 160 cm-1, D-band around 1,300 cm-1, tangential G-band
around 1,580 cm-1, and D*-band around 2,600 cm-1.
Scanning electron microscopy (SEM) technique was used to look at the
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morphology of sugar dendron-functionalized nanotube samples. Shown in Figure 2.4.5
are SEM images for the Gal2-SWNT sample, for which the specimen was prepared by
drop-casting an ultra-thin film from the sample solution. Abundant nanotubes are
observed, with their being randomly oriented at the edge of the specimen (Figure 2.4.5a)
but more ordered in the fractured portion of the same specimen (Figure 2.4.5b). For Gal4SWNT, a very dilute aqueous solution was used to prepare the SEM specimen
(depositing a few drops and then evaporating the water). The image shows generally
dispersed nanotubes (Figure 2.4.6).
The thermal defunctionalization behavior of the dendron-SWNT samples is very
different from those of many other functionalized carbon nanotubes.30 The functional
groups (sugar dendrons) could not be removed from the nanotubes in thermogravimetric
analysis (TGA) scans (under inert atmosphere to 800°C), and instead they were
carbonized under the thermal defunctionalization conditions. Therefore, the usually
effective TGA estimate of nanotube contents in the functionalized samples was not
applicable, and the compositions in dendron-SWNT samples were determined in terms of
sugar analyses.
The sugar contents in the dendron-SWNT samples were quantified by
spectrophotometry with the anthrone reagent.21 Results thus obtained for the sample
compositions are shown in Table 2.4.2. There are no meaningful differences in sample
compositions between Gal- and Man-, Gal2- and Man2-, or Gal4- and Man4- as functional
moieties, despite the fact that the Gal-based functionalization agents are consistently less
effective (a lower percentage of starting purified SWNTs solubilized) than their Man-
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(a)

500 nm

(b)

200 nm

Figure 2.4.5 SEM images of a Gal2-SWNT specimen (ultra-thin film): (a) at the edge
of the specimen; and (b) in the fractured portion of the specimen.
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500 nm

Figure 2.4.6 SEM image of the Gal4-SWNT specimen (on carbon-coated cupper grid)
prepared from a very dilute sample solution.
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Table 2.4.2. Compositions in the Functionalized Nanotube Samples and Related
Parameters.

a

Sugar
Content a

SWNT
Content a

Average No. of
Nanotube Carbon
per Sugar Unit

Aqueous Solubility
(SWNT-equivalent,
mg/mL)

Starting
SWNTs
Solubilized
(%)

Gal-SWNT

45%

43%

14

0.83

11%

Man-SWNT

47%

42%

13

0.84

22%

Gal2-SWNT

44%

19%

6

1.7

20%

Man2-SWNT

45%

18%

6

1.6

35%

Gal4-SWNT

37%

23%

9

3.1

27%

Man4-SWNT

35%

29%

11

4.3

50%

The remaining (100% - sugar content - SWNT content) is the content of linkers/tethers.
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based counterparts in the nanotube solubilization (Table 2.4.2). The poorer solubilization
performance of the Gal-based agents is probably due at least in part to the significantly
lower (by a factor of 3 to 4) aqueous solubility of galactose than that of mannose.31
The known sample compositions also allow the calculation for the average
number of nanotube carbons per sugar unit in the samples (Table 2.4.2). From Gal- (or
Man-) to Gal2- (or Man2-), the number decreases significantly, namely that more sugars
are displayed on the same amount of SWNTs. For Gal4-SWNT and Man4-SWNT, even
though there is no advantage in the number of sugars displayed (because of the relatively
larger amount of tethering moieties for the display), the improved aqueous solubility and
the specific configuration of β-D-galactoses or α-D-mannoses displayed in quartet may
offer properties that are not available to other configurations.
It has been reported that Gal-SWNT binds to E. coli O157:H7 to result in
significant cell agglutination.17 The same assay was used to evaluate the binding of Gal2SWNT with the same E. coli strain. As shown in Figure 2.4.7, there was obviously
significant aggregation of the cells in the presence of Gal2-SWNT. The amount of
aggregates (precipitates at the bottom of the centrifuge tube) was larger for a higher
starting E. coli concentration of 108 cells/mL than that of 5 × 107 cells/mL (Figure 2.4.7).
Between Gal2-SWNT and Gal-SWNT under similar experimental conditions, the amount
of recovered aggregates was clearly larger in the former than in the latter (Figure 2.4.7).
This was reflected more quantitatively in results from the CFU reduction assay. As
compared in Figure 2.4.8, Gal2-SWNT was obviously more effective in the agglutination
of E. coli O157:H7 cells to result in a more significant CFU reduction. Mechanistically,
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a

b

c

d

Figure 2.4.7 Fluorescence microscopy images (10 µm for all scale bars) on the
agglutination of E. coli O157:H7 (GFP-expressing) cells by (a) Gal2SWNT, (b) Gal-SWNT, and (c) the control (cells only). (d) A visual
comparison on the amount of precipitates (in centrifuge tubes)
associated with the agglutination of E. coli O157:H7 cells (top: 5×107
cells/mL, and bottom: 108 cells/mL) by Gal2-SWNT (left) and GalSWNT (right). (Courtesy of Dr. P. J. Luo)
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Figure 2.4.8 Results from the CFU reduction assay for E. coli O157:H7 in the
presence of Gal2-SWNT, Gal-SWNT, and PBS only as control.
(Courtesy of Dr. P. J. Luo)
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Figure 2.4.9 Optical microscopy images (75 µm for all scale bars) on the aggregation
of B. subtilis spores (a) Man-SWNT, (b) Man2-SWNT, and (c) Man4SWNT in the presence of calcium cation. (Courtesy of Dr. H. Wang)
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the binding responsible for the cell agglutination is attributed to specific ligand-receptor
interactions of the nanotube-displayed β-D-galactoses with E. coli surface galactosebinding-protein.17 The more favorable binding by Gal2-SWNT seems to suggest that the
paired galactoses could be more effective in the specific interactions. However, the multivalent binding of carbohydrates with cell surface receptors is a complicated
phenomenon.1,2,32 A more definitive conclusion requires more systematic investigations
with these and other assays.
The complexity with desired quantitative evaluations of the sugar-functionalized
SWNTs in binding assays is also reflected in the results on B. subtilis spores. B. subtilis is
a commonly used nonvirulent simulant for Bacillus anthracis (anthrax),33 with surface
expressed with various carbohydrates.33 As reported previously for B. anthracis (Sterne)
spores,18 Man-SWNT also binds to B. subtilis spores for their significant aggregation in
the presence of calcium cation (Figure 2.4.9). Similarly, Man2-SWNT and Man4-SWNT
are both capable of binding and aggregating B. subtilis spores in the same assay, as also
illustrated in Figure 2.4.9. However, a more quantitative comparison of the different α-Dmannose-functionalized SWNTs samples was hindered by other issues beyond simply the
different displays of mannoses in Man2-SWNT and Man4-SWNT. For example, it was
found that for Man2-SWNT samples of somewhat different Man/nanotube ratios (from
slight variations in reaction conditions in the synthesis) their bindings with the spores
(and the associated degrees of aggregation) were obviously different. Such effects were
more pronounced in the binding assay of Man4-SWNT with B. subtilis spores in the
presence of calcium cation. Especially for Man4-SWNT samples of slightly higher

141

Man/nanotube ratios, the binding assay resulted in well-dispersed aggregates of an
irregular rod-like shape (20-50 microns in length and 5-10 microns in diameter according
to optical microscopy analyses). We speculate that some of these complications might be
due to the divalent cation-mediated interactions between the paired α-D-mannoses in
Man2-SWNT and Man4-SWNT, which could be competing with the binding with cell
surface receptors. Further investigations are required for a better understanding of the
results.

2.4.4 Summary
In

summary,

a

series

of

dendritic

β-D-galactopyranosides

and

α-D-

mannopyranosides with a terminal amino group were synthesized and used for the
functionalization of SWNTs targeting the defect-derived carboxylic acid moieties on the
nanotube surface. The functionalized nanotube samples were characterized by using
established NMR, optical spectroscopy, and microscopy techniques. The results suggest
that the higher-order sugar dendrons are more effective in the solubilization of SWNTs,
with the corresponding functionalized nanotube samples of improved aqueous solubility
characteristics, and that the nanotube is indeed a unique pseudo-one-dimensional scaffold
for displaying multiple copies of the sugar molecules in pairs or quartets. These
multivalent carbohydrate configurations may potentially offer interesting chemical and
biochemical properties and functions, despite some of the complications that are yet to be
understood (as reflected in the results of the binding assay with B. subtilis spores).
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CHAPTER III
OTHER INTERESTING OR UNIQUE PROPERTIES OF
SUGAR-FUNCTIONALIZED CARBON NANOTUBES
3.1 Carbohydrate-Carbohydrate Interactions Unique To
Monosaccharide Ligands Tethered Single-Walled
Carbon Nanotubes
3.1.1 Introduction
Cell recognition and adhesion are the initial step in a set of basic cellular
processes such as cell migration and differentiation.1 Three known interactions, proteinprotein interaction, protein-carbohydrate interaction, and carbohydrate-carbohydrate
interaction, are the forces manipulating cell recognition and adhesion.2 Studying these
interactions thus is fundamentally important to an understanding of basic cellular
behaviors. Among tremendous studies in this field, most are limited to the self
recognition of proteins, only a few focused on carbohydrates involving interactions,
especially interactions among carbohydrates. This is because carbohydrate-carbohydrate
interaction is usually very weak and co-exists with two other interactions.3 This problem
was partially solved in early 1990’s, by mimicking natural multivalent ligands, the
interaction of two carbohydrate clusters could be orders of magnitude stronger than that
of the two single carbohydrates.4 Since then, many multivalent carbohydrate models
have been developed to study carbohydrate interactions, such as three-dimensional (3D)
glycol gold nanoparticles employed to study self adhesion process of trisaccharide Lewisx
and disaccharide lactose,5 glycol dendrimers,6 glycol polymers,7 and two-dimensional
(2D) self assembled carbohydrate cluster on gold surface8 for the investigation of protein-

carbohydrate interaction.
Recently, our group reported a new pseudo-one-dimensional multivalent model
by using single walled carbon nanotube (SWNT) as scaffold to display monosaccharides
(such as β-D-galactose) as multivalent ligands.9 The galactose-functionalized SWNT
(Gal-SWNT) material exhibits special ability of aggregating E. Coli O157:H7 cells
through the likely ligand-receptor interaction between the tethered galactose and
galactose-binding protein on the cell surface (see chapter 2.2). Another recent study of
the same material showed a unique cation (Ca2+)-mediated binding ability to Bacillus
anthracis (Sterne) spores.10 This study inspired us that there could be Ca2+ ion-mediated
self-recognition in the nanotube-based multivalent monosaccharide system. After
systematic studies, we reported here that there are indeed monosaccharidemonosaccharide interactions that are unique to the nanotube-bound sugars.

3.1.2 Experimental Section
Materials. CaCl2 and ethylendiaminetetraacetic acid (EDTA) were purchased
from Fisher. The series of sugar-functionalized SWNT samples: Man-SWNT, GalSWNT, Man2-SWNT, Gal2-SWNT, Man4-SWNT, and Gal4-SWNT, were prepared via
typical carbodiimide-activated amidation between the sugar-tethered amino group and the
nanotube-bound carboxylic acid group. The as-produced sugar-functionalized nanotube
samples formed blackish but optically transparent aqueous solutions that were stable for
months’ storage. The microscopy studies showed that the nanotubes were substantially
debundled to individual tubes or thin bundles with their electrical properties being largely
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unchanged. More details on the preparation and characterization have been provided in
chapter 2.4.
Atomic Force Microscopy (AFM). Analysis of the samples was conducted on a
Molecular Imaging PicoPlus system equipped with a multipurpose scanner. The height
profile analyses were assisted by using the SPIP software distributed by Image
Metrology. Sample specimen was prepared by spaying onto a heated mica substrate.
Optical Microscopy. Sample specimen was prepared by dropping a small aliquot
(10 µl) of the sample onto a glass slide, then covered with cover glass and imaged with
the differential interference contrast (DIC) model on a Leica DMIRE2 microscopy
coupled to a Leica TCS SP2 laser scanning device and equipped with Leica HC PL APO
10*/0.30 and 20*/0.70 objectives.
Scanning Electron Microscopy (SEM). SEM images were obtained on a Hitachi
S4700 field-emission SEM system. Sample specimen was prepared by first depositing the
sample onto the filter paper (Whatman, nuclear pore polycarbon filter paper, 200 nm
diameter) by filtration. Upon washing with ethanol solution and critical point drying, the
final specimen was mounted on an aluminum stub with double-sided carbon tape and
coated with platinum.

3.1.3 Results and Discussion
It is well-known that carbohydrate-carbohydrate interaction is closely related to
divalent cation,3a,11 especially Ca2+ ion which has the ideal ionic radii (0.99 Å) to form
stable carbohydrate-metal complex. In the literature, Ca2+ ion has been effectively used

149

as the interacting medium to study self-adhesion among the trisaccharides3,5 and the
disaccharides.12 In this study, CaCl2 (20 mM, 200 µL) was first added into a 2mL ManSWNT sample (mannose concentration around 0.4mg/mL, Figure 3.1.1a). The tiny black
particles (aggregates) were formed immediately (observed easily by naked eyes), the
small particles kept aggregating and started precipitation within 10 mins (Figure 3.1.1bd), and after 1 hr, all the aggregates dropped down to the bottom of the vial and the upper
solution changed to colorless (Figure 3.1.1e). The optical absorption spectrum of the
upper solution became totally blank, meaning that it hardly contained any Man-SWNT
sample. The same aggregation was observed in the experiment with Gal-SWNT sample
(one tenth diluted from as-produced Gal-SWNT sample), and the results are showed in
Figure 3.1.2.
To study the morphology of the initially formed aggregates at microscopic level,
optical microscopy images of the freshly generated (within half min) Man-SWNT or GalSWNT aggregates were captured. As shown in Figure 3.1.3, the shape of the aggregates
is either round or irregular. According to a statistical measurement of 1,202 Man-SWNT
particles, the particle size varies from few micrometers to 100 µm, but most are within
the range of 10 to 20 µm (Figure 3.1.3d). Considering that the size of an individual ManSWNT is around several nanometers wide and a few micrometers long, those large
aggregates suggest an ultra-fast self-aggregation among Man-SWNTs or Gal-SWNT
upon adding Ca2+.
The scanning electron microscopy (SEM) was also conducted to have a closer
look at the morphology of the Man-SWNT/Gal-SWNT aggregates formed at very early
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stage. As shown in Figure 3.1.4, the Man-SWNT/Gal-SWNT was randomly aggregated
to form particles with different size varying from hundreds of nanometers to a few
micrometers. A high-resolution image of Gal-SWNT particles showed nanotubes were
crosely aggregated together, and each particle contained more than 10 individual or thinbundled nanotubes (Figure 3.1.4b).
To further examine the reason behind the aggregation, an EDTA-Na solution (40
mM, 200 µL) was added into the Man-SWNT precipitates. The Man-SWNT precipitates
re-dispersed into the solution very fast and soon a blackish transparent Man-SWNT
solution was recovered (Figure 3.1.1f-g). The re-dispersed Man-SWNT solution
preserved same absorption curve as that of starting Man-SWNT sample (Figure 3.1.5b),
and two typical absorption bands of the SWNTs at ~1036 nm (S22) and ~718 nm (M11)
were preserved (Figure 3.1.6), which means that the aggregation/re-dispersion cycle does
not affect the electronic properties of the Man-SWNT samples, and the Ca2+-induced
Man-SWNT aggregation is reversible by adding EDTA-Na. The similar EDTA-enabled
re-dispersion of nanotubes was also observed in Gal-SWNT aggregation.
The reversibility of the aggregation is also supported by atomic force microscopy
studies. Showed in Figure 3.1.7 is the AFM comparison of the original and re-dispersed
Man-SWNT/Gal-SWNT samples. Most re-dispersed nanotubes stayed individually or in
thin bundles as the original nanotubes, and no entangled nanotubes like those in Figure
3.1.3-b were found. Comparing to the starting Man-SWNT/Gal-SWNT samples (Figure
3.1.7a,b), the surface of the re-dispersed nanotubes is not very smooth, probably due to
the deposition of the EDTA-Ca salts during the preparation of the AFM specimen. The
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Ca2+/EDTA mediated aggregation/redispersion cycle of Man-SWNT/Gal-SWNT samples
can be repeated for many times (Figure 3.1.1h-n and 3.1.2e-g). In addition to Ca2+ cation,
other divalent cations, such as Mg2+ and Ba2+, are also capable to aggregate ManSWNT/Gal-SWNT (Figure 3.1.8).
Before drawing the final conclusion on the force causing the aggregation of ManSWNT/Gal-SWNT samples, a set of control experiments were conducted. CaCl2 (100
mM) was added into four controls including the mannose-functionalized polymeric
nanoparticles (Man-NP, the mannose content about 5 wt%), the galactose-functionalized
polymeric nanoparticles (Gal-NP, the galactose content about 4.7 wt%), the BSAfunctionalized SWNTs (BSA-SWNT), and the poly(ethylene glycol)-functionalized
SWNTs (PEG-SWNT), none of them generated aggregates (Figure 3.1.9a-d). Another
control experiment was carried out by adding NaCl (50 mM) into the Man-SWNT/GalSWNT solution, and no aggregation was observed either (Figure 3.1.9e-f).
Combining all these results, we now have sufficient evidence to conclude that the
aggregation is caused by the divalent cation-mediated monosaccharide-monosaccharide
interaction. First, Ca2+ ion only induces the aggregation of mannose- or galactosefunctionalized SWNTs, not the BSA- or PEG-functionalized SWNTs at all, indicating
that monosaccharide is an essential element for aggregation. Second, removing Ca2+ ion
by adding EDTA reverses the aggregation, characteristic of the kind of carbohydratecarbohydrate interactions. Third, the aggregation is only triggered by divalent cation
(Ca2+, Mg2+ or Ba2+) instead of cations of other valence (such as Na+ ion), also
characteristic of the kind of carbohydrate-carbohydrate interactions.3,5,11-12 Therefore, the
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Figure 3.1.1 The repeatable solution-aggregation/precipitation-redispersion cycle
of the mannose-functionalized SWNT sample. An as-prepared ManSWNT solution (a); after adding CaCl2 solution and waited for 5 (b),
10 (c), 30 (d), 60 (e) minutes to observe the aggregates and
precipitates; precipitation re-dispersed into the solution by adding
EDTA-Na (f and g). A repeat of the same precipitation (h-k) and redispersion (l-n) cycle.
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Figure 3.1.2 In a solution of 100 µL of original Gal-SWNT sample mixed with 900 µL
of water (a), 100 µl of 20mM CaCl2 solution was added and waited for 5
min (b), 60 min (c), then 50 µL of 40 mM EDTA-Na solution was added
(d), another 100 µL 20 mM CaCl2 was added again and waited for 5 min
(e), 30 min (f), and finally, the mixture was added 200 µL of 40 mM
EDTA-Na solution (g).
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Figure 3.1.3 Optical micrographs showing the Ca2+-induced aggregation of (a,c)
Man-SWNT, (b) Gal-SWNT, and (d) a size distribution analysis of
freshly formed Man-SWNT aggregates upon adding CaCl2.
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Figure 3.1.4 SEM images showing the Ca2+-mediated aggregates of (a): ManSWNT at a low magnification and (b): Gal-SWNT at a high
magnification.
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Figure 3.1.5 Optical absorption spectra (in H2O) of (a): the supernatant of the post
centrifuged sample shown showed in Figure 3.1.1e; (b): the aqueous
Man-SWNT solution before adding Ca2+; and (c): the recovered ManSWNT solution from the sample showed in Figure 3.1.1g.
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Figure 3.1.6 Vis/NIR absorption spectra of the Man-SWNT solution in D2O
(solid line) and the same solution but after experiencing one
aggregation/re-dispersion cycle induced by adding Ca2+ and then
EDTA (dashed line).
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Figure 3.1.7 AFM phase images of (a): Man-SWNT and (b): Gal-SWNT; and the
amplitude images of (c): Man-SWNT with Ca2+ then EDTA-Na and
(d): Gal-SWNT with Ca2+ then EDTA-Na.
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Figure 3.1.8 Photos of (a): a Man-SWNT solution; (b): the Man-SWNT aggregation
upon adding Mg2+ cation; and (c): the re-dispersed Man-SWNT
solution after adding EDTA-Na solution; and similarly (d): a GalSWNT solution; (e): the Gal-SWNT aggregation upon adding Mg2+
cation; and (f): the re-dispersed Gal-SWNT solution after adding
EDTA-Na solution.
(Note: The results were similar with the use of divalent cation Ba2+
instead of Mg2+.)
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Figure 3.1.9 Controls of (a): Gal-NP + Ca2+ solution, (b): Man-NP + Ca2+ solution;
(c): BSA-SWNT + Ca2+ solution; (d): PEG-SWNT + Ca2+ solution;
(e): Man-SWNT + Na+ solution; and (f): Gal-SWNT + Na+ solution.
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Figure 3.1.10 The mixtures of Ca2+ (100 mM) with sugar dendron-functionalized
SWNTs (from left to right): Man2-SWNT, Man4-SWNT, Gal2SWNT, and Gal4-SWNT.
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specific binding effect between the divalent cation and the nanotube-tethered
monosaccharides is the only reasonable explanation on the self-aggregation of the
monosaccharide-functionalized SWNT samples (Scheme 3.1.1a).
An interesting fact here is that although Man-SWNT/Gal-SWNT aggregates
strongly in the presence of Ca2+, Man-NP/Gal-NP hardly aggregates at all. In the
literature on those spherical gold glyconanoparticle models, Penadés’s group reported
self-recognition of the trisaccharides Lewisx on 2nm gold nanoparticles,5 and Russell et
al. observed interaction among disaccharide lactoses-coated 16nm gold nanoparticles,12b
but no similar interaction between monosaccharides was ever reported. It seems that the
observed monosaccharide-monosaccharide interaction in our work is unique to the
SWNT-displayed monosaccharides.
Ca2+ involves in sugar-sugar interaction through forming coordinate bonds among
sugars.2c,12 Most naturally enriched monosacchrides, such as mannose, galactose and
glucose, are short of a-e-a sequence of hydroxyl group (which is the optimal geometry
for the complexing site with Ca2+) in their most stable state.12 Therefore, in general, free
monosaccharides rarely coordinate with Ca2+ in aqueous solution. However, the studies
of the C-type (Ca2+ dependent) mannose-binding protein (MBP)13 and galactose-binding
lectin14 all suggest that monosaccharides, under certain condition, could bind with Ca2+ in
solution.
The nanotube-displayed multivalent sugars, when compared with the particledisplayed ones, apparently have at least two unique characters: one is their onedimensionally displayed morphology due to SWNT; and the other is their non-uniform
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distribution on the nanotube due to the nature of the nanotube defect-site
functiionalization. Therefore, it is possible that the nanotube-displayed monosaccharides
have a special local morphology that tends to bind to Ca2+ even in solution. On the other
hand, due to the intrinsically hydrophobic nature and the size of the nanotubes and the
limited number of the carbohydrates that are attached to the nanotubes, the
monosaccharide-functionalized SWNTs might have a lower solubility than glycol gold
nanoparticles, which makes them more sensitive to weak interactions among
monosaccharides.
Another

interesting

observation

is,

against

our

expectation,

that

the

monosaccharide (galactose and mannose)-based dendrons in their functionalized
nanotube samples, including Man2-SWNT, Gal2-SWNT, Man4-SWNT, and Gal4-SWNT,
have very weak aggregation response toward Ca2+. There was no immediate aggregation
observed even at a very high Ca2+ concentration (100 mM), though there were some
aggregates formed after a few days, but with most of the functionalized nanotubes still
well dispersed in solution (Figure 3.1.10). Comparing the α-D-mannose- or β-Dgalactose- functionalized nanotubes to their dendron-functionalized ones, a major
difference is that the latter have much higher sugar density and better aqueous solubility,
thus may be less sensitive to monosaccharide-monosaccharide interactions. Another
possible explanation is that since sugars are more densely packed in the sugar dendron
functionalized SWNTs, they may tend to interacted with each other near by instead of
with the one on the other nanotubes, thus cause much less nanotube aggregations
(Scheme 3.1.1b).
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Scheme 3.1.1 A schematic illustration for Ca2+ mediated carbohydratecarbohydrate interaction in (a) mono-sugar functionalized
SWNTs and (b) sugar dendron functionalized SWNTs.
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As we implied before, the research on carbohydrate-carbohydarate interactions is
still at an early stage, and most current multivalent models are only suitable for a
qualitative demonstration of those weak interactions. The efficiency of the demonstration
is largely affected by the nature of the models, such as the size, morphology, solubility,
and so on. Nerveless, our α-D-mannose- and β-D-galactose-functionalized nanotube
systems obviously demonstrate the kind of unique interactions among monosaccharides.

3.1.4 Summary
In summary, we have firstly demonstrated the self recognition of the
monosaccharides in solution. The interaction is unique to the monosaccharide ligands
displayed on SWNTs. Although the detail mechanism of the interaction is still unknown,
the special conformation of the nanotube bonded sugars and the unique nature of the
nanotube might play the critical roles for this monosaccharide-monosaccharide
interaction. And the SWNT carried multivalent carbohydrate ligands might be used as a
versatile model to further study similar carbohydrate involved weak interactions.
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3.2 Selective Interactions of Sugar-Functionalized Single-Walled
Carbon Nanotubes with Bacillus Spores
3.2.1 Introduction
Potential applications of nanomaterials in biological field, such as biosensors and
drug delivery, have attracted significant interest in recent years due in part to the
dimensional proximity of these materials to biomacromolecules (e.g. proteins and DNAs)
and some small organisms (e.g. viruses and bacteria).1,2 In these applications, the
nanomaterials are usually used as scaffolds for the display of multiple copies of bioactive
functional groups,2-5 making interactions of the bio-nano conjugates more significant than
simply the free bioactive molecules with target biological species. For example, α-Dmannose-tethered polymeric nanoparticles were shown to bind to E. coli cells (with
mannose receptors) to induce massive cell agglutination, but no similar binding and
agglutination were found with the use of free α-D-mannose molecules.2b
Carbon nanotubes, especially single-walled ones (SWNTs), are typical “onedimensional” nanomaterials because of their small diameters and large aspect ratios. The
unique structure of the carbon nanotubes makes it a favored platform than other
nanoscale carriers in the above mentioned interactions with biological species.4,5 For
example, we previously reported that SWNTs displaying multiple monosaccharides,
either α-D-mannose (Man-SWNT) or β-D-galactose (Gal-SWNT), could bind to Bacillus
anthracis spores in the presence of Ca2+, resulting in significant spore aggregation and
substantial reduction in colony forming units (CFU).5 These were attributed to the Ca2+mediated multivalent interactions between SWNT-displayed carbohydrates and spore
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surface carbohydrates. The aggregation phenomenon was observed only with the use of
nanotube scaffolds, and absent if polymeric nanoparticles or no nano-substrate was used
instead.5
The ongoing exploration of Bacillus spores and their surface structure related to
the binding with various species has been of significant interest due to the importance in
the countermeasure of bioterrorism threats with B. anthracis.6 Although only a partial
understanding of the outermost layers of the Bacillus spores is available, a number of
studies have been carried out to investigate the interactions of these spores with
molecules such as peptides,7 lectins,8 and carbohydrates.9 Following our previous
investigation on B. anthracis spores, here we reported a similar Ca2+ mediated binding of
monosacchride-coated SWNTs (Man-SWNT and Gal-SWNT) to Bacillus subtilis (a
nonvirulent simulant for B. anthracis) spores. Beyond that, it was found that Man-SWNT
can bind to and aggregate B. subtilis spores in the absence of Ca2+. The binding was
specific to α-D-mannose-functionalized SWNTs and B. subtilis spores, suggesting
carbohydrate-protein interactions as a possible mechanism for the direct binding (without
divalent cation mediation) of Man-SWNT to B. subtilis spores.
It is gratefully acknowledged that all spore-related experiments reported and
discussed here were performed by Dr. Haifang Wang, also assisted and participated by
Dr. Pengju (George) Luo and others, in our research group.

3.2.2 Experimental Section
Materials. The monosaccharide-functionalized single-walled carbon nanotubes
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(Man-SWNT and Gal-SWNT) were prepared by using the same procedures detailed in
chapter 2.2. The α-D-mannose- and β-D-galactose-coated polymeric nanoparticles were
synthesized according to the literature.2b-c
Bacillus Spore Preparation. B. subtilis ATCC33234 (American Type Culture
Collection, Manassas, VA) spores were prepared by using a modified procedure from the
literature.10 Briefly, B. subtilis cells were grown at 37 °C in solid Difco sporulation
medium (DSM) until sporulation was essentially complete. Vegetative cells and spores
were collected from medium plates, washed extensively with cold (4 °C) sterile distilled
water, and pelleted by centrifugation. The pellet was re-suspended in a solution of TrisMg buffer (pH 8.0) that contained lysozyme at a concentration of 1 mg/mL.
Subsequently, the suspension was shaken slowly for 1 h at 37 °C. Then NLaurylsarcosine was added to a concentration of 2%, and the solution was incubated for
30 min. The spores were then pelleted and washed 4 times with sterile cold distilled
water. Finally the spores were re-suspended in cold sterile distilled water and stored at 4
°C until further use. The purification of spores was further checked through spore
staining and phase contrast microscopy.
Binding Assays. Ca2+-mediated binding assays of Man-SWNT or Gal-SWNT and
B. subtilis spores were carried out by following previous procedures.5 The binding assays
without Ca2+ were conducted as follows. An aqueous suspension of B. subtilis spores (20
µL, 105 CFU/µL) was mixed with a test solution (20 µL) or with distilled water (20 µL,
as control). The mixtures (sample and control) were rotated for 16 h before being
examined visually and under microscopes.
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Optical Microscopy. A small aliquot of 10 µL sample from above binding assay
was dropped onto a glass slide and covered with a cover slip. The specimen was imaged
in the differential interference contrast (DIC) mode on a Leica DMIRE2 microscopy
equipped with a Leica TCS SP2 laser scanning device and Leica HC PL APO 10*/0.30
and 20*/0.70 objectives.
Scanning Electron Microscopy (SEM). The sample mixture from above binding
assay was centrifuged at 6800g for 5 min. The pellet was washed with distilled water in
centrifuging-suspending cycles, and the final pellet was suspended for the fixing and
post-fixing treatment according to established procedures.11 The final specimen upon
critical point drying was mounted on an aluminum stub with double-sided carbon tape
and coated with platinum. SEM images were obtained on a Hitachi S4700 field-emission
SEM system.
Colony Forming Units (CFU) Reduction Assays. Similar to the CFU reduction
assay used previously for the Ca2+-mediated binding of B. anthracies,5 a suspension of B.
subtilis with the spore count of 2.6 × 108 (in 40 µL) was mixed with a test sample (40 µL)
or with distilled water as control. After 30 min, an aqueous CaCl2 solution (20 µL, 100
mM) was added with gentle mixing, followed by rotation at room temperature for about
12 h. The mixtures (samples and control) were centrifuged at a low speed (25 g) for 1
min. A portion of each supernatant (40 µL) was used for the assay. Upon serial dilution,
the diluted samples (0.1 mL each in triplicate) were spread evenly on solid TSA medium
plates for incubation at 37 °C for about 12 h. The plates were counted, and the percentage
CFU reduction was calculated in reference to the control.
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For the binding without Ca2+, a suspension of B. subtilis with the spore count of 2
× 108 (in 40 µL) was mixed with a solution of test sample (40 µL) or with distilled water
(as control). After being rotated at room temperature for about 16 h, the mixtures (sample
and control) were treated in the same procedures as described above for the Ca2+mediated binding.

3.2.3 Results and Discussion
Due to high pathogenicity of B. anthracis spore, the genetically closely related B.
subtilis spore has usually been used as a simulant. Albeit only a little has been known
about the spore surface, current knowledge suggests that the spore surface is mainly
constructed by glycoproteins and carbohydrates.12-13 For example, various carbohydrates
including rhamnose, 3-O-methyl rhamnose, and galactosamine, were identified on B.
anthracis spore surface,12 whereas quinovose and other unique sugars were isolated on
the coat of B. subtilis spore.13
We recently reported Ca2+-mediated carbohydrate-carbohydrate interactions
between monosaccharide-functionalized SWNTs (Man-SWNT and Gal-SWNT) and B.
anthracis spores, resulting in significant spore aggregation.5 Since B. subtilis spore
surface also expresses various carbohydrates, this kind of interaction should exist in B.
subtilis system as well. To explore this possibility, binding assays of Man-SWNT and
Gal-SWNT with B. subtilis spores were conducted in the presence of Ca2+. Both ManSWNT and Gal-SWNT were found binding and aggregating B. subtilis spores in the
presence of Ca2+. As shown in Figure 3.2.1a, the spores were aggregated to form larger
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clumps to the size of 20 -100 microns. Considering the normal size of a single spore at ~1
micron in diameter and ~2 microns in length, these spore clumps definitely contained
hundreds to thousands of aggregated spores. The SEM images gave a closer view of the
spore aggregation (Figure 3.2.1b-c). The spores were clearly embedded in a network
constructed by the nanotubes. The spore aggregation could be re-dispersed by the
addition of the EDTA sodium salt solution (100 µL, 20 mM), suggesting the existence of
the expected carbohydrate-carbohydeate interactions between the nanotube-displayed
monosaccharides and sugars on the B. subtilis spore surface.
Under the experimental condition, the CFU reductions for B. subtilis spores
aggregated owing to the Ca2+-mediated binding with Man-SWNT (0.2 mg/mL mannose
equivalent) and Gal-SWNT (0.15 mg/mL galactose equivalent) were found to be 80%
and 67%, respectively (Figure 3.2.2). The free mannose and mannan (a polymannose) as
well as mannose- or galactose-coated polymeric nanoparticles (data not shown) did not
show any spore reduction compared to the control, indicating that the binding was unique
to carbon nanotube-displayed multiple sugars.
To further evaluate the binding potential of Man-SWNT to B. subtilis spores, the
CFU reductions in the presence of various divalent cations and at different Ca2+
concentrations were conducted (Figure 3.2.3). The results showed that the increase in
Ca2+ concentration would help to achieve higher CFU reduction. At the Ca2+
concentration of 25 mM, the CFU reduction of the spores was 70%, and improved to
87% when the Ca2+ concentration was raised to 250 mM.
The Ca2+ mediates carbohydrate-carbohydrate interactions by forming coordinate
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a

25 µm

b

2 µm

c

700 nm

Figure 3.2.1 Optical micrograph (a) and SEM image (b) of the aggregation of B.
subtilis spores induced by Ca2+-mediated binding with Man-SWNT;
(c) A high-resolution SEM image showing the Ca2+-mediated
interactions of Gal-SWNT with B. subtilis spores. (Courtesy of Dr.
H. Wang and Dr. P. J. Luo)
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Figure 3.2.2 The CFU reduction (% of control) for B. subtilis spores aggregated
owing to the Ca2+-mediated binding with (a) 5 mg/mL Mannose; (b) 5
mg/mL Mannan; (c) Man-SWNT, 0.2 mg/mL mannose equivalent; and
(d) Gal-SWNT, 0.15 mg/mL galactose equivalent. The Ca2+
concentration is 100 mM. (Courtesy of Dr. H. Wang and Dr. P. J. Luo)
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Figure 3.2.3 The CFU reduction (% of control) for B. subtilis spores aggregated
owing to the binding with Man-SWNT in the presence of various
divalent cations (Mg2+, Ca2+, and Ba2+) and at different
concentration of Ca2+ (25 mM to 250 mM). (Courtesy of Dr. H.
Wang and Dr. P. J. Luo)
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bonds among sugars. Other divalent cations, such as Mg2+ and Ba2+, have been shown in
the literature for the similar coordinating effect on carbohydrates.14 In our study here, we
found that Mg2+ and Ba2+ could indeed mediate the binding of Man-SWNT to B. subtilis
spores. As suggested by CFU reduction results, at a divalent cation concentration of 100
mM, the binding efficiency in terms of CFU reduction is in the order of Mg2+ < Ca2+ <
Ba2+ (Figure 3.2.3). Apparently a larger diameter cation is favored in mediating the
binding of Man-SWNT to B. subtilis spores, which is consistent with the literature
report.14d
The carbohydrate-carbohydrate interactions rely on divalent cations, which
explains our previous finding of the Ca2+-dependency in binding of Man-SWNT or GalSWNT to B. anthracis spores.5 A similar Ca2+-dependence was found in the B. subtilis
spore aggregation study with Gal-SWNT. In the absence of divalent cation, Gal-SWNT
can not induce any detectable spore aggregation (Figure 3.2.4d). However, the ManSWNT was found to aggregate B. subtilis spores even in the absence of the divalent
cation. As shown in Figure 3.2.4a, the B. subtilis spore aggregates could easily be
identified in optical micrograph. A closer examination with SEM imaging showed that B.
subtilis spores in the aggregates are “wrapped” by the functionalized SWNTs (Figure
3.2.4b-c). Although these spore aggregates were relatively small in size and loosely
packed as compared to what were observed in Ca2+-mediated aggregations, it was
obviously caused by specific binding instead of nonspecific adsorption.
The CFU reduction due to B. subtilis spore aggregation in direct binding with
sugar-coated nanomaterials showed that Man-SWNT had a 53% reduction while Gal-
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a

5 µm

b

c

d

Figure 3.2.4 Optical micrograph (a) and SEM images (b,c) of the aggregation of
B. subtilis spores induced by direct binding with Man-SWNT; and a
SEM image (d) showing no binding between Gal-SWNT and B.
subtilis spores. (Courtesy of Dr. H. Wang and Dr. P. J. Luo)
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Figure 3.2.5 The CFU reduction (% of control) for B. subtilis spores aggregation due
to the direct binding with (a) Man-SWNT, 0.2 mg/mL mannose
equivalent; (b) Mannose functionalized polymeric nanoparticles, 0.25
mg/mL mannose equivalent; (c) Gal-SWNT, 0.15 mg/mL galactose
equivalent; and (d) Galactose functionalized polymeric nanoparticles,
0.52 mg/mL galactose equivalent. (Courtesy of Dr. H. Wang and Dr.
P. J. Luo)
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SWNT and α-D-mannose/β-D-galactose-functionalized polymeric nanoparticles did not
cause any reduction (Figure 3.2.5). Therefore, the binding of Man-SWNT to B. subtilis
spores is unique to the α-D-mannose-functionalized SWNTs and also specific to B.
subtilis spores (no direct binding to B. anthracis spores observed).
Although the detailed binding mechanism of Man-SWNT to B. subtilis spores is
still under investigation, it is unlikely due to the carbohydrate-carbohydrate interactions
because it is Ca2+-independent. Since the B. subtilis spore coat is composed primarily of
proteins, the observed highly specific binding could most likely be attributed to
carbohydrate-protein interactions between the nanotube-bound α-D-mannose moieties
with the B. subtilis spore surface protein receptors. Although such carbohydrate-protein
interactions are relatively weak, they do exist and are highly specific, with the addition of
the divalent cation Ca2+ to bring in the additional binding due to carbohydratecarbohydrate interactions, both kinds of interactions contributing to the binding and
aggregating of B. subtilis spores with Man-SWNT. This may partially explain the results
that Man-SWNT has a higher binding efficiency (as suggested by the CFU reduction)
than Gal-SWNT in the Ca2+-mediated aggregation of B. subtilis spores.

3.2.4 Summary
Carbon nanotubes represent a unique displaying scaffold for multivalent
monosaccharide ligands. The monosaccharide-functionalized SWNTs were found to
effectively bind and aggregate B. subtilis spores in the presence of a divalent cation. The
observation was consistent with our previous report on B. anthracis spores. A new
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finding reported here is that the α-D-mannose-functionalized SWNTs were capable of
binding to B. subtilis spores without the divalent cation. This direct binding is unique to
the nanotube-bound α-D-mannose and specific to B. subtilis but not B. anthracis spores.
The selectivity may be exploited in the study of spores in the anthrax family for improved
understanding of their surface structures and functions.
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APPENDICES

List of the Abbreviations

Atomic force microscope...........................................................................................AFM
Bacillus anthracis ........................................................................................... B. anthracis
Bacillus subtilis..................................................................................................B. subtilis
Bovine Serum Albumin ............................................................................................. BSA
Colony-forming units..................................................................................................CFU
N, N'-dicyclohexyl-carbodiimide............................................................................... DCC
N,N’-dimethyl-4-aminopyridin ............................................................................... DMAP
N, N'-dimethyl Formamide ........................................................................................DMF
1-ethyl-3-(3-dimethylaminopropyl) carbodiimide...................................................EDAC
Ethylendiaminetetraacetic acid ...............................................................................EDTA
Escherichia coli ...................................................................................................... E. coli
β-D-Galactose ….........................................................................................................GalMatrix-assisted laser desorption/ionization .......................................................... MALDI
α-D-Galactose ............................................................................................................ManMulti walled carbon nanotubes........................................................................…MWNTs
N-hydroxysuccinimide................................................................................................NHS
Nuclear magnetic resonance ..................................................................................... NMR
Phosphate Buffered Saline.......................................................................................... PBS
Scanning electron microscope ................................................................................... SEM
Single walled carbon nanotubes............................................................................ SWNTs
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Transmission electron microscope............................................................................. TEM
Thermo Gravimetric Analysis.................................................................................... TGA
Tetrahydrofuran .......................................................................................................... THF
Time-of-flight mass spectrometry........................................................................TOF-MS
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